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With aging, our cognitive abilities gradually decline relative to our cognitive 
performance in young adulthood. For example, older adults’ performance on tasks 
that rely on memory, reasoning, spatial visualization, and speed declines 1. These 
changes are accompanied with physical changes in the brain. For instance, gray and 
white matter intensity decreases in frontal, anterior cingulate and temporal regions 2. 
Although the decline in cognitive performance can be measured in experimental 
tasks, most older adults experience no or only a modest decline in daily life. In some 
areas – for instance vocabulary knowledge - they even outperform younger adults. 
This is a domain in which life experience plays a more important role than in, for 
example, information processing speed. Thus, the aging brain may compensate for 
physical shortcomings to achieve a normal behavioral performance. One hypothesis 
states that diminished neural activity of a brain region with difficulties can be 
compensated by activity in alternate connected brain networks.
In fact, during our entire lifespan, the brain is continuously optimizing the use of its 
resources. It does so by changing neural pathways to adjust for changes in behavior 
(e.g. learning) or shortcomings due to brain trauma 3. For example, existing neural 
connections may need to be strengthened or other unaffected brain structures must 
be allocated. In addition, neural pathways that are not activated frequently enough 
may be pruned. An example is the extensive synaptic pruning in the young child’s 
brain 4. At first glance, it may seem odd that a child’s developing brain eliminates 
nerve tracts, but this way, only functional connections will remain and the brain’s 
efficiency is largely increased. 
These different aspects of neuroplasticity have long been considered to be a 
characteristic exclusive to the young developing brain. Thus, the aging brain was 
traditionally considered to be static and only subject to a progressive deterioration of 
neural tissue and consequently a decline in performance. In the last decades, it has 
been discovered that this view is incorrect. Fortunately, the aging brain maintains its 
neuroplastic capacities to a large degree 3. This gives rise to the thought that the 
aging brain might be capable of some form of compensation for its decline in 
cognitive resources.
In adults, the fully developed brain has dealt with all kinds of tasks in the past and is 
able to efficiently allocate its resources to reach an optimal performance. When the 
usual resources are scarce or insufficient, the brain may compensate for this by 
optimizing the activity in the existing network or by increasing activity in an alternate, 
connected network 5. This way, the desired behavioral output can still be achieved. To 
achieve a certain goal, the brain strives to be as energy-conservative, and 
consequently efficient, as possible. How the brain achieves this, probably differs 
12
CHAPTER 1
from sample to sample, e.g. whether the sample exists of healthy people or certain 
patient groups. Even differences from individual to individual, depending on age, sex, 
comorbidities are a possibility.
Studying how compensatory networks are allocated in patients with (neuro)
psychological disorders might open up new directions for treatment and prevention. 
A personalized approach in medicine appears destined to become a reality with 
increasing research focusing on this topic. Insight into neural network recruitment in 
clinical samples is an important first step. However, it is vital to first understand 
individual recruitment of neural (compensatory) networks in healthy older adults 
before we can study this in clinical samples. The issue with studying compensatory 
activation is that it is a phenomenon that is happening within the proverbial black box. 
By its nature, it is nearly impossible to study compensatory activation by only 
recording behavioral performance. Therefore, there is a need to investigate the source by 
studying the activation in the brain that underlies the behavioral output. One method 
to directly study brain activity is the human electroencephalogram (EEG), which has 
been developed and described by Hans Berger 6. The EEG method allows a non- 
invasive approach to measure electrical brain potentials at the surface of the scalp.
The event-related potential (ERP) is brain activity in the EEG that is related to the 
neural processing of an event. Such an event can be, for example, someone calling 
out your name, a traffic light turning green, an off-key note in a melody, or a stimulus 
in an experimental paradigm. The ERP consists of several peaks and troughs that 
can be identified by their post-stimulus latency, baseline-related amplitude, base-
line-relative polarity and order of occurrence in the ERP. The ERP to a single stimulus 
consists of neural activity related to the event as well as neural activity unrelated to the 
event, and additional artifacts and noise (unrelated to the processing of the stimulus). 
One way to eliminate this non-event-related activity is by presenting a multitude of 
stimuli and averaging all EEG segments that are phase-locked to the repeated stimuli. 
The averaging increases the signal to noise ratio of the signal. That is, the neural 
activity related to the processing of the stimulus remains, and simultaneously the 
spontaneous activity that is unrelated to the processing of the stimulus is reduced.
Figure 1.1 demonstrates an example of a typical (averaged) ERP and its peaks and 
troughs that have been related to different aspects of cognitive processing. The 
peaks and troughs in the ERP span a continuum ranging from exogenous to 
endogenous potentials. Exogenous potentials are related to responses to the 
physical nature of a stimulus. Endogenous potentials are related to the internal 
processing of the stimulus 7.
13
INTRODUCTION
1
The earlier peaks and troughs are predominantly related to exogenous processes 
(not illustrated). For example, the amplitudes of these peaks can be manipulated by 
differences in stimulus loudness or tone frequency 7. The later occurring peaks and 
troughs, referred to as the N1, P2, N2 and P3, are related to endogenous processing. 
For example, the N1 has been related to spatial orientation 8. The N2, which occurs 
around 200 milliseconds post-stimulus, has been associated with attentional and 
mismatch processing 9. The P3 is in general the largest and most prominent positive 
peak in the ERP. In young, healthy adults it occurs at approximately 300 milliseconds 
after stimulus presentation and is therefore also known under the moniker ‘P300’. 
Since the P3 is the most prominent ERP peak it has been the most extensively studied 
ERP component since its discovery in the early 1960s. 
A classic ERP paradigm to elicit the P3 is known as the ‘oddball’ paradigm 10. In the 
auditory form of this paradigm a participant is presented with a sequence of beeps. 
Intermixed within this sequence are other beeps that occur less frequent than the 
frequent stimuli, hence oddball stimuli, and differ for instance in pitch, loudness, or 
duration. The deviating oddball beeps elicit a P3 peak that is not present in the 
frequent stimuli. This effect is not limited to auditory stimuli though. The P3 is also 
elicited with deviating visual, tactile, or olfactory stimuli, or even when expected 
stimuli within a regular sequence are occasionally omitted, as long as the infrequent 
Figure 1.1   A schematic overview of the ERP. A typical averaged event-related 
potential consists of several peaks and troughs named after their polarity 
and order of occurrence, i.e. N1, P2, N2 and P3.
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target stimuli deviate from the frequent background stimuli. Figure 1.2 demonstrates 
the oddball paradigm in a schematic manner.
The P3 that is elicited in this oddball paradigm is sensitive to a wide range of 
experimental manipulations that impact on endogenous information processing. For 
instance, one can decrease the probability of the infrequent target stimulus, thus 
manipulating the participants’ expectancy to increase the P3 amplitude 11,12. In 
addition to manipulating the target probability, increasing the task difficulty and 
thereby the mental effort a participant has to devote to the task has been positively 
correlated with the P3 amplitude as well 13,14. However, uncertainty, which can be 
introduced by making the difference between the background and target stimulus 
less salient, is negatively correlated to the P3 amplitude 13. Apart from experimental 
manipulations, the P3 is additionally determined and influenced by biological and 
physiological determinants, such as sex, circadian rhythm, fatigue, food intake or 
psychoactive substances 15. 
The possibility to elicit the P3 by deviant stimuli has led to the conventionally accepted 
proposition that the P3 reflects cognitive processes that are related to detection of this 
deviance. Several theories have been postulated to explain what cognitive processes 
the P3 reflects. For instance, the stimulus-evaluation-hypothesis by Duncan-Johnson 
and Kopell (1981) 16 states that the P3 reflects information processing related to the 
evaluation of the presented stimulus. An even more influential theory is the con-
text-updating theory by Donchin (1981) 17. This theory states that participants, for 
instance in the oddball paradigm, create a mental context based on the stimuli that 
are presented to them. When a deviating stimulus is presented, the previously 
established mental context is no longer accurate and needs to be updated to account 
for the new information the deviating stimulus introduces. It is proposed that an 
increased P3 reflects the updating process. There are several alternative, yet similar, 
theories. For instance, the context-closure hypothesis by Verleger (1988) 18 states that 
participants create a meaningful mental context after stimulus presentation. However, 
Figure 1.2  A schematic overview of the oddball paradigm.
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in this theory the P3 is thought to reflect the closing of a mental epoch when a 
deviating stimulus is presented to the participant. 
Although all the hypotheses acknowledge the involvement of several cognitive 
processes, 50 years of intensive research on the P3 still cannot link this elusive wave 
in the ERP to one specific cognitive process. One reason is that the P3 probably 
reflects multiple cognitive processes (e.g., perception, attention, working memory, 
executive processes) that overlap in time. This is probable since the P3 encompasses 
such a large portion of the entire ERP duration (again see figure ERP) and often 
contains multiple subcomponents. Although the P3 lacks specificity, the multifarious-
ness of the P3 makes it a suitable index of cognitive functioning in general and such 
a general cognitive measure can especially be valuable in studying information 
processing in mental aging. In addition, the P3 has other characteristics that make it 
a suitable measure. First, an individual’s specific P3 morphology - predominantly 
determined by that person’s physiological properties, like skull thickness and 
anatomical features of the corpus callosum - is a remarkably stable measure with 
little variation over recording sessions 19. Second, the P3 is the most recognizable 
ERP component, which makes it easy to determine its amplitude and latency at the 
level of individual participants. Third, the paradigms used to elicit the P3 are generally 
short and simple and are therefore suitable for studying a wide range of participants 
across a large portion of the lifespan (i.e., from 5 years old onwards). Fourth, recording 
an ERP is a relatively affordable and quick non-invasive procedure that most people, 
including those of older ages, can endure with ease.
Aim and outline
This thesis aims to investigate whether the P3 is a valid index to quantify cognitive 
aging in both healthy and clinical populations. By doing so, it aims to capture the 
compensatory brain activation that might increase with aging.
After this general introduction, Chapter 2 describes a systematic review and 
meta-analysis of healthy aging effects on the parietal P3 potential across the lifespan. 
Consequently, trajectories describing the development of the P3 (latency and 
amplitude) with aging are formed. Additionally, the results from the meta-analysis are 
validated in a large cross-sectional data set. In Chapter 3 tears apart the 
developmental trajectories of the parietal P3 and compares them to the developmental 
trajectories of the frontal P3 in order to capture differences between both P3s’ 
development and aspects of frontal compensation with aging, again in healthy 
participants. Chapter 4 provides an overview of the role of EEG and ERPs in 
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predicting treatment outcome leading to Chapter 5, in which differences in P3s 
between healthy and clinical (Major Depressive Disorder) participants as well as its 
use in predicting treatment outcome in a large sample, are reported. Finally, in 
Chapter 6 the P3 is decomposed into independent components (using independent 
component analysis) to capture a more accurate and localizable reflection of frontal 
compensation. The decomposed P3s are compared between young and old 
participants and are localized to a cortical source. Chapter 7 discusses the main 
findings and implications of the studies and suggestions for future research.
17
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A review of the 
age-related development of the P3
Published as:
van Dinteren, R., Arns, M., Jongsma, M.L.A., & Kessels R.P.C. (2014).  
P300 development across the lifespan: a systematic review and meta-analysis. 
PLOS One, 9, e87347
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Abstract
Background: The P3 component of the event-related potential is a large positive 
waveform that can be extracted from the ongoing electroencephalogram using a 
two-stimuli oddball paradigm, and has been associated with cognitive information 
processing (e.g. memory, attention, executive function). This paper reviews the 
development of the auditory P3 across the lifespan. 
Methodology/Principal findings: A systematic review and meta-analysis on the P3 
was performed including 75 studies (n=2,811). Scopus was searched for studies 
using healthy subjects and that reported means of P3 latency and amplitude 
measured at Pz and mean age. These findings were validated in an independent, 
existing cross-sectional dataset including 1,572 participants from ages 6-87. 
Curve-fitting procedures were applied to obtain a model of P3 development across 
the lifespan. In both studies logarithmic Gaussian models fitted the latency and 
amplitude data best. The P3 latency and amplitude follow a maturational path from 
childhood to adolescence, resulting in a period that marks a plateau, after which 
degenerative effects begin. We were able to determine ages that mark a maximum 
(in P3 amplitude) or trough (in P3 latency) segregating maturational from degenerative 
stages. We found these point of deflection occurred at different ages.
Conclusions/Significance: It is hypothesized that latency and amplitude index 
different aspects of brain maturation. The P3 latency possibly indexes neural speed 
or brain efficiency. The P3 amplitude might index neural power or cognitive resources, 
which increase with maturation.
21
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Introduction
Almost half a century ago, the group of Samuel Sutton and E.R. John first described 
the P3 11, a component from the event-related potential (ERP), which has been 
intensively investigated since then. However, despite abundant research on this 
component, its developmental path across the lifespan has been relatively 
underexposed. The present paper will review and analyze the developmental process 
of the auditory P3 across the lifespan employing 1) a systematic review and 
meta-analysis of all studies published over the last half century and 2) an independent 
cross-sectional dataset including 1,572 participants. The P3 developmental process 
is proposed to reflect development of cognitive speed and cognitive capacity, across 
the lifespan.
Characteristics of the P3
The ERP is quantified by averaging activity in the electroencephalogram (EEG) 
time-locked to a specific event, for instance an auditory stimulus. This results in a 
waveform associated with the processing of that specific event. The ERPs found in 
such tasks have a characteristic waveform with clearly identifiable components, 
which are named after their polarity and approximate latency (i.e., P100, N100, P200, 
N200, P3). The P3 (also referred to as P3) component of the auditory ERP is a large 
positive waveform that reaches a maximum at approximately 300 milliseconds after 
stimulus onset (see figure 2.1 for an example). The amplitude is defined as the voltage 
difference between a pre-stimulus established baseline and the largest positive peak 
within a predefined latency window 14.
The P3 is commonly elicited in signal-detection tasks. A typical signal-detection 
paradigm is the ‘oddball’ paradigm that was first used by Ritter and Vaughan 10. In the 
auditory version of this paradigm, participants are typically presented with two 
different tones that can be discriminated based on, for example, pitch or loudness. 
The different types of tones are presented with different probabilities (e.g., 20% vs. 
80%). The frequent stimuli are designated as background stimuli, the infrequent 
stimuli as target or oddball stimuli to which the participant must respond, for example 
by counting or pressing a button 10,20,21. See figure 2.1 for a schematic overview of the 
oddball.
In addition to the traditional P3 that is associated with responding to infrequent target 
stimuli, a slightly earlier P3 peak has been reported, which has slightly shorter 
latencies and a more frontally oriented topography. This component has also been 
labeled as P3a 22-25, and has primarily been linked to stimulus novelty and is not 
necessarily related to the generation of responses. This peak can be observed in, for 
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example, a modified three-stimulus oddball paradigm including a second infrequent 
stimulus. Consequently, the P3 component described earlier has also been labeled 
P3b. Throughout this paper we will use the term P3 to reflect the P3b.
P3 theories
A central theme in P3 research is the exact nature of the involved cognitive processes 
underlying the P3, and several theories have been postulated in this respect. First, 
the stimulus-evaluation hypothesis states that the latency of the P3 component 
reflects the time needed for stimulus evaluation processes and is independent of the 
time needed for response processes16. However, this theory has been refuted in a 
more recent review26,27. A more prominent hypothesis, which has its roots in Sokolov’s 
orienting response model and links the P3 to cognitive functioning, is the context-up-
dating hypothesis17,20,21. This hypothesis states that the P3 (amplitude) represents 
brain activity related to updating a mental stimulus representation when deviant 
stimuli are presented. That is, the participant’s mental model of his/her environment, 
or context, is evaluated and updated when a relevant and deviant stimulus is 
presented14,17,21. Finally, as an alternative to the context-updating hypothesis, the con-
text-closure hypothesis has emerged. This hypothesis links the P3 to deactivation 
Figure 2.1  Schematic overview of the oddball paradigm and an example of an ERP.
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processes, consequent upon the closure of a perceptual epoch. The hypothesis 
states that participants combine repeatedly presented stimuli in meaningful contexts. 
Deviating target stimuli, after a series of non-deviating background stimuli, close 
such a context and this closure process is reflected by the P3 18,21,28. 
Although these hypotheses recognize the involvement of various cognitive processes, 
still, after almost 50 years of intensive research with over 12,000 publications on the 
P3 it has not been possible to link the P3 to a specific cognitive process. Presumably, 
the P3 complex is multifarious, reflecting a culmination of multiple cognitive processes. 
However, there is evidence that shorter P3 latencies and larger amplitudes are 
associated with superior information processing 20,21,29-32. In addition to individual 
differences due to trait effects, the P3 is also influenced by state variables, that is, 
natural and induced biological factors – like body temperature, sleep quality, exercise, 
food intake, drugs – which are mediated by arousal levels 15. Thus, an interaction of 
cognitive processes and arousal levels determine relative changes in the P3, that is, 
component latencies and amplitudes. The absolute P3 morphology is predominantly 
determined by an individual’s physiological properties, such as anatomical features 
of the corpus callosum 33 or skull thickness 34. Thus despite relative changes by state 
variables, a person’s specific P3 morphology is a remarkably stable measure that 
shows little variation over recording sessions or experiments 19. In line, P3 morphology 
has demonstrated a high heritability of approximately 60% 35. The main aim of the 
current review is to unravel the P3’s development across the lifespan based on data 
obtained from both a meta-analysis and systematic review of existing papers and an 
independent large standardized dataset. First, a descriptive model of P3 development 
across the lifespan will be presented. This model will then be used to describe the 
development of information processing in terms of cognitive speed and resources.
Age effects on the P3 latency
Research on P3 development across the lifespan has been relatively scarce. However, 
there is clear evidence that P3 latency decreases during the first years of life 36-39, 
whereas in older adults the parietal P3 latency increases 40-43. This model describing 
initial maturation followed by degenerative effects of aging on latency indicates that 
there may be a specific age range that marks a point of deflection in P3 latency 
development. To our knowledge, this specific trough of the P3 latency has not been 
described yet.
Age effects on the P3 amplitude
Findings on early developmental processes in P3 amplitude are mixed. P3 amplitudes 
are found to either increase during childhood or show no change 36,37,39,44. Capacity of 
information processing increases rapidly during early childhood, which is expected 
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to enhance the P3 amplitudes. However, an opposing effect on amplitudes may 
result from an increase in skull thickness, as a thicker skull is related to smaller 
amplitudes 34. Indeed, a study by Beauchamp et al. found an increasing brain-scalp 
distance as children age 45. Thus, cranial development during childhood probably 
moderates early P3 amplitude development.
In adulthood, a decline of the parietal P3 amplitude with advancing age is commonly 
reported 40-43. Since smaller P3 amplitudes have been associated with a decreased 
performance on a variety of cognitive tests indexing different aspects of information 
processing 21, they might thus reflect aging-related cognitive decline.
Behavioral task performance
An elegant aspect of the oddball paradigm is the possibility to quantify psychophys-
iological measures – i.e., the P3 latency and amplitude as described above – with 
their consecutive behavioral measures, such as reaction times (RTs) and errors. 
Speed variables – like RTs – have moderate to large associations with age during 
adulthood 46. Therefore, RTs have been hypothesized to be an index of aging-related 
cognitive decline. In general, measures of speed tend to share 75% of the age-related 
variance with a variety of cognitive measures 46. Thus, directly linking behavioral 
measures to the analysis of P3 latency and amplitude could result in new insights into 
the underlying neurocognitive mechanisms of the P3 across the lifespan.
The present review
First, a systematic review and meta-analysis will be performed, in order to model P3 
developmental trajectories across the lifespan. The results of this review will be used 
to investigate effects of paradigm and sample characteristics on P3 latency and 
amplitude. Based on a literature review published by Polich (1996), besides age, an 
effect of stimulus saliency attributes, like stimulus intensity, stimulus duration and 
number of stimuli, is expected 21. 
Second, based on an independent multi-site, cross-sectional dataset of 1,964 healthy 
participants aged 6-87 years – who all performed the same paradigm under 
standardized recording conditions and identical task procedures – an age-based 
model of the P3 across the lifespan will be estimated. In addition, the effects of within 
subject variables such as sex and education will be investigated further.
Finally, the estimated developmental trajectory of the P3 latency and amplitude will 
be compared to the developmental trajectory of behavioral measures such as 
reaction times and number of errors. Previous research has demonstrated that the P3 
latency shows a significant positive correlation with reaction times 14.
25
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Methods
Meta-analysis
Literature search
A systematic review was performed using Scopus with the search phrase “P300 OR 
P3b AND oddball”, starting on June 18th 2012 until October 10th 2012. The search was 
not conducted according to a specific review protocol. All article titles and summaries 
were scanned for selection criteria. When the summary provided insufficient 
information, the methods section of the article was read. The following criteria were 
used to assess eligibility of articles for the meta-analysis:
a) The study had to report data on healthy participants not diagnosed with any 
neurological, psychiatric or other disorder which have a significant impact on the 
P3. When such information was not reported, a study could not be included. In 
studies that used a clinical population, only data from the healthy control 
participants were included.
b) The study had to report a mean age and a mean P3 latency and/or P3 amplitude 
for the healthy participants. These measures had to be reported quantitatively. 
Studies that reported only P3 data in graphs were excluded.
c) Studies with fewer than 15 participants in total were excluded in order to prevent 
Type-I errors 21,47,48.
d) Studies had to employ an auditory, active (meaning a response required from the 
participant on the oddball), two-stimulus (auditory stimuli differing in frequency) 
oddball paradigm. These criteria were based on relevant parameters mentioned 
in Polich (1996). The current meta-analysis focused on (binaurally) auditory 
paradigms since this is in accordance with the paradigm used in the cross-sec-
tional data set.
e) P3 data for the Pz electrode site had to be available.
f) Study results had to be available in English.
g) Meta reviews and overlapping data sets (i.e., multiple papers on the same 
sample) were excluded.
h) Studies using the BRID database (REF: www.brainnet.net) were excluded, since 
data from this database were included in part 2 of this study.
The literature search resulted in a total of 1,265 studies. The literature review by Polich 
(1996) was checked manually for additional references that fulfilled the search 
selection criteria since it served as a basis for the current meta-analysis 21. This 
yielded 26 additional studies resulting in a total of 1,291 studies. Figure 2.2 
presents a flowchart depicting the number of studies that were excluded and the 
reasons for exclusion. Exclusion rationale was scored only once per study, and 
the main reason was noted. Therefore, some of the studies in figure 2.2 may 
meet multiple exclusion criteria.
26
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Data extraction
The resulting 75 studies that were used in the meta-analysis are listed in table S1 with 
study details. The data entered per study are listed below:
1) Year was defined as the year of publication
2) Continent (if not clear, the first author’s affiliation was used)
3) Number of participants was recorded as detailed as possible. So when data was 
divided over several age groups the data for each group were recorded. This 
applies to all data mentioned below
4) Percentage of males (if available)
5) Mean age
6) Mean P3 latency in milliseconds (and standard deviation if available)
7) Mean P3 amplitude in microvolts (and standard deviation if available)
Figure 2.2   Flowchart depicting the number of exclusions per exclusion rationale in 
the literature selection.
27
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In addition, recording parameters were also extracted. The parameter selection was 
based on Polich (1996) and included 1) eyes open/eyes closed if reported; 2) 
response type (press or count); 3) stimulus duration; 4) stimulus intensity; 5) absolute 
tone frequency difference between target and background. Additionally, 6) target 
probability; 7) total number of stimuli and 8) inter-stimulus interval were scored.
After the initial selection of appropriate studies, efforts were made to retrieve missing 
data by contacting the authors. All data were entered in a single spreadsheet using 
Microsoft Excel 2011. This spreadsheet was fully double checked for transcription 
errors by a second independent rater.
Outlier removal
One study reported a mean amplitude that was four standard deviations from the 
general mean and greatly affected average amplitude data 49. The authors from this 
study mentioned several factors that may have attributed to the high amplitude 
scores they found, namely, the use of a low target probability, large inter-stimulus 
intervals, morning assessments and the use of a group of young adults 49. Therefore, 
this study was considered an outlier and excluded from the analyses.
Statistical analysis
Visual inspection of the graphed latency data revealed a suspected inversed 
Gaussian pattern for the latency data. The latency data were transformed by inversing 
the scores and adding a constant (i.e., 600) in order to fit a model to the data. 
Transformation of the amplitude data was not necessary.
The data were entered in Graphpad Prism 6.0. Every datapoint consisted of a mean 
age and mean P3 latency or amplitude value. Prism has the possibility to include 
standard deviation and sample size in the calculations and these measures were 
entered when they were available. Several models were fitted to the data including a 
normal Gaussian, a logarithmic Gaussian and a straight line. The Gaussian models 
are described by three parameters; its center, width and amplitude. Center is the x 
value at the peak of the distribution; width is a measure of the width of the distribution 
expressed in the same units as x; amplitude is the height of the center of the 
distribution expressed in y units (www.graphpad.com). The model’s amplitude is 
referred to as height to avoid confusion with the P3 amplitude.
In addition, one-way ANOVAs were performed to investigate the effect of eyes open/
closed and response type. The other predictors were investigated using regression 
analysis. These predictors were entered in two blocks. The first block contained 
predictors based on the meta-analysis by Polich (1996) and included: percentage of 
28
CHAPTER 2
males, number of stimuli, and stimulus duration. The second block included: target 
probability, stimulus loudness, frequency difference between target and background 
tone, inter-stimulus interval. Then, the regression model was refined by entering only 
those predictors that showed an effect with a significance of p < 0.10. For the final 
regression model a significance level of p < .01 was used.
Cross-sectional dataset
Ethics Statement
All participants gave written informed consent. Local independent review board 
approval was obtained for all clinics.
Participants
Normative data were extracted from the Brain Resource International Database 
(BRID) resulting in a dataset of 1,964 healthy participants. This database contains 
data from multiple laboratories (New York, Rhode Island, Nijmegen, London, Adelaide, 
and Sydney) using standardized data acquisition techniques (identical amplifiers, 
standardization of other hardware, audio calibration, paradigm details, software 
acquisition, and task instructions). Inter-lab reliability and test-retest reliability 
measures are high and have been reported elsewhere 19,50,51. 
Participants were aged 6 to 87 (mean = 28.38 ± 20.08). The sample consisted of 992 
male and 972 female participants. Education scores varied from 1 to the maximum 
possible score of 18 years of education (mean = 10.89 ± 4.46). Database exclusion 
criteria included a personal or family history of mental illness, brain injury, neurological 
disorder, serious medical condition, drug/alcohol addiction, first-degree relative with 
bipolar disorder, schizophrenia, or genetic disorder. Participants were required to 
refrain from caffeine and smoking for at least 2 hours and alcohol for at least 6 hours 
prior to testing.
Six participants with error rates of 33% or higher on false positive errors (button press 
on a background stimulus) or false negative errors (no button press on a target 
stimulus) were considered unreliable and removed from the dataset (as an indication 
they have not understood the task instructions appropriately). The remaining 1,958 
participants were matched for age and sex by random selection, resulting in a further 
exclusion of 386 participants. The resulting dataset consisted of 786 males and 786 
females matched for age (mean = 27,17 ± 19.16; range = 6-87 years).
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Electroencephalographic data acquisition
EEG and ERP recordings were performed using a standardized methodology and 
platform (Brain Resource Ltd., Australia). Details of this procedure have been 
published elsewhere 19,52. 
In summary, participants were seated in a sound and light attenuated room, controlled 
at an ambient temperature of 22 °C. EEG data were acquired from 26 channels: Fp1, 
Fp2, F7, F3, Fz, F4, F8, FC3, FCz, FC4, T3, C3, Cz, C4, T4, CP3, CPz, CP4, T5, P3, Pz, 
P4, T6, O1, Oz and O2 (Compumedics Quikcap and NuAmps amplifier; 10-20 
electrode international system). Data were offline referenced to averaged mastoids 
with a ground at Fpz. Horizontal eye movements were recorded with electrodes 
placed 1.5 cm lateral to the outer canthus of each eye (bipolar). Vertical eye 
movements were recorded with electrodes placed 3 mm above the middle of the left 
eyebrow and 1.5 cm below the middle of the left bottom eyelid. Skin resistance was 
<5 kOhms for all electrodes. A continuous acquisition system was employed and 
EEG data were EOG corrected offline 53. The sampling rate of all channels was 500 
Hz. A high cut-off filter at 100 Hz was employed prior to digitization. P3 latency and 
amplitude were quantified at Pz.
Auditory oddball
The oddball paradigm consisted of a quasi-random sequence of 280 frequent 
background tones (500 Hz) and 60 infrequent target (1000 Hz) tones. Two targets 
could not appear consecutively. All stimuli (50 ms; 5 ms rise and fall time) were 
presented binaurally at a volume of 75dB SPL with an inter-stimulus interval of 1000 
ms. Participants were instructed to press two buttons simultaneously (one for each 
index finger) when they heard a target tone and to ignore the background tones. 
Speed and accuracy of response were both equally stressed in the instructions. 
Before the actual test they were presented with a brief practice run to clarify the 
distinction between the two tones.
Statistical analysis
Effects of age, sex and education on P3 latency and amplitude were investigated. 
Using Graphpad Prism 6.0, non-linear regression analyses by means of a curve fit 
were carried out for both latency and amplitude across the lifespan. Three different 
models were compared by an extra sum-of-squares F test. In addition, a one-way 
ANOVA was used to investigate sex effects. The significance level was set at p < .01 
due to the large sample size. Also, separate curves were determined for males and 
females and were statistically compared. Education effects were investigated in a 
subgroup of adults using regression analysis.
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Effects of age, sex and education on behavioral measures were also studied. The 
procedure for reaction times was identical to the latency analysis. Additionally, 
correlations between reaction times and P3 latency and amplitude were investigated. 
Lastly, correlations between the number of errors, and age, latency, amplitude and 
reaction time were investigated.
Results
Meta-analysis
Study characteristics
There were 75 studies selected for the meta-analysis. These were published between 
1987 and 2012. All participants together (n=2,811) had a mean age of 33.3 ranging 
from 4 to 95 years. The overall mean P3 latency was 316.5 milliseconds (range: 290.0 
- 447.5) and the overall mean P3 amplitude was 10.4 microvolts (range: 2.6 - 37.7).
Psychophysiology
Figure 2.3a shows the P3 latency across the lifespan as obtained from the 
meta-analysis. A logarithmic Gaussian model was the best fit when compared to a 
(normal) Gaussian model (F(1,2511)=76.90; p<.0001) or a linear model (F(1,1569)= 
330.6; p<.0001) and accounted for approximately 19% of the variance. The model 
reveals a trajectory in which the P3 latency decreases during childhood, reaching a 
trough around an age of 22 years, followed by a slow increase for the rest of the 
lifespan.
The P3 amplitude trajectory is shown in figure 2.3b. For amplitudes a logarithmic 
Gaussian model was also the best fit when compared to a (normal) Gaussian model 
(F(1,2146)=121.6; p<.0001) or a linear model (F(1,2146)=24.39; p<.0001). The model 
accounted for 9% of the variance. The maximum P3 amplitude was estimated at an 
age of 16 years.
Paradigm parameters and within-subject characteristics
Effects of paradigm parameters and within-subject characteristics were investigated 
in a subgroup in which age effects on latency and amplitude were linear so that 
regression analysis was possible. This subgroup was defined by the high end of the 
95% confidence interval for the age center value, respectively for latency (age 25.5) 
and amplitude (age 22.5), until the age of 65.
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Figure 2.3   P3 latency and amplitude trajectories across the lifespan as obtained 
from the meta-analysis. Dots represent (subgroups from a) study.  
Error bars represent SEM.
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For latency, one-way ANOVAs for eyes open/closed (F(1,18)=1.084) and response 
type (F(1,48)=2.478) were not statistically significant. These variables were therefore 
not included in the regression analysis. The other predictors were entered in a 
regression model in two blocks. Block 1 of the regression model revealed no 
significant predictors apart from age. Block 2 revealed target probability, stimulus 
duration and inter-stimulus interval as possibly significant predictors. These were 
entered in a final regression model that was not significant.
For amplitude, one-way ANOVAs for eyes open/closed (F(1,21)=2.112) and response 
type (F(1,54)=0.011) were not significant. These variables were therefore not included 
in the regression analysis. The same predictors as in the latency model were entered 
in block 1 and block 2. Block 1 of the regression analysis revealed possibly significant 
effects of percentage of males and number of stimuli. Block 2 revealed a possibly 
significant effect of stimulus loudness. These three predictors were entered into a final 
regression model. Table 2.1 lists the results. The regression model was significant for 
amplitude (F(3,17)=10.317; p<.001; R2=.65). Higher numbers of (summated 
background and target) stimuli and louder stimuli were associated with lower P3 
amplitudes.
Cross-sectional dataset
Next, the 1,964 healthy participants from the cross-sectional dataset were used to 
model age-related development of the P3 latency and amplitude.
Psychophysiology
In figure 2.4a the P3 latency is plotted against age. The results of the independent 
cross-sectional dataset demonstrated a similar trajectory compared to the 
meta-analysis. P3 latency decreases during childhood, reaching a minimum in 
Table 2.1  Predictors from the final regression model for P3 amplitude
Amplitude
B ± SE β
Constant 25.99 ± 5.85
Male % 0.11 ± 0.06 .30
Number of stimuli -0.02 ± 0.01 -.37a
Stimulus loudness -0.16 ± 0.05 -.51b
R2 = .65. a p < .05; b p < .01
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adolescence, followed by a slow increase for the rest of the lifespan. A logarithmic 
Gaussian model accounted for 18% of the variance and this was significantly better 
than a (normal) Gaussian model (F(1,1569)=179.3; p<.0001) or a linear model 
(F(1,1569)=330.6; p<.0001). In the cross-sectional dataset the minimum latency is 
estimated at approximately 25 years of age.
The P3 amplitude logarithmic Gaussian model is demonstrated in figure 2.4b. The 
model was able to explain 12% of the variance and this was significantly better than 
a (normal) Gaussian model (F(1,1569)=108.8; p<.0001) or a linear model 
(F(1,1569)=162.4; p<.0001). The maximum amplitude was reached at approximately 
21 years of age. 
Demographics
A main effect of sex was found in one-way ANOVAs on both latency (F(1,1570)=12.606; 
p<.001; ω2=.01) and amplitude (F(1,1570)=10.499; p=.001; ω2=.01), albeit with small 
effect sizes (ω2=.01 is considered a small effect 54). Separate curves for males and 
females demonstrated similar developmental trajectories of latency and amplitude. 
The curve fit statistics can be found in Table 2.2. None of the individual curve-fit 
parameters for the latency and amplitude models reached significance below the 
p<.01 level. 
Education effects were only investigated in a subgroup. The subgroup was defined 
by the high end of the respective 95% confidence intervals of centers for the latency 
(age is 25.5) and amplitude (age is 22.5) models until the age of 65. This group was 
selected since at the age of 25 most individuals will have completed their educational 
career. The upper cut-off was chosen to minimize a possible bias due to degenerative 
effects at older age. An additional advantage is that in this subgroup age-related 
effects on latency and amplitude can be described linearly. Regression analysis 
revealed no effects of education on P3 latency or amplitude in the subgroup as can 
be seen in Table 2.3.
Table 2.2  p-values of differences between male and female model parameters
Latency Amplitude RT
Center .488 .032 .596
Width .455 .306 .482
Height .026 .053 <.001
All .001 .001 <.001
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Figure 2.4   P3 latency and amplitude trajectories across the lifespan as obtained 
from the cross-sectional dataset. Dots represent scores from individual 
participants.
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Behavioral measures
Reaction time was transformed by the same method used for P3 latency. A logarithmic 
Gaussian model was then fitted on the transformed reaction time data. The model 
accounted for 35% of the variance and this was significantly better than a (normal) 
Gaussian model (F(1,1569)=830.2; p<.0001). The reaction time model resembles the 
model for P3 latency. This is confirmed by a significant partial correlation (corrected 
for age) between reaction time and the P3 latency (r=.30; p<.001). Pearson’s 
correlation coefficient indicates a medium effect size 55. The fastest reaction times are 
estimated at an age of approximately 32 years of age.
A one-way ANOVA revealed a significant effect of sex (F(1,1570)=24.26; p<.001; 
ω2=.01), albeit with a small effect size. Separate models for male and female 
participants’ reaction times confirm the sex effect. These models differ significantly 
(F(3,1566)=12.31; p<.0001) and show that males respond faster than females over 
all ages. There were no effects found for age and education in the subgroup, see 
table 2.3.
Partial correlations, correcting for age, between number of errors and P3 latencies 
and amplitudes were investigated. Because of the non-linear relation between age 
and both P3 measures the group was divided in young and older participants. Young 
participants were defined as all participants below the age of 20.36, which marks the 
Table 2.3. Regression analyses on latency, amplitude and reaction times
Latency Amplitude Reaction time
B ± SE β B ± SE β B ± SE β
Step 1
Constant 320.17 ± 4.77 19.45 ± 0.86 325.34 ± 16.02
Age 0.79 ± 0.10 .33b -0.15 ± 0.20 -.30b 0.09 ± 0.28 -.02
Sex 5.90 ± 2.54 .10a 1.82 ± 0.53 .138b 13.18 ± 5.33 .13a
Step 2
Constant 316.28 ± 9.21 19.48 ±2.14 304.98 ± 23.57
Age 0.81 ± 0.11 .33b -0.16 ± 0.02 -.31b -0.03 ± 0.28 -.01
Sex 5.71 ± 2.57 .09a 1.71 ± 0.53 .13b -14.14 ± 5.39 -.14b
Education 0.24 ± 0.48 .02 -0.16 ± 0.10 -.06 1.14 ± 0.97 .06
Latency: R2 = .11 for Step 1, ΔR2 = .000 for Step 2 (NS). Amplitude: R2 = .11 for Step 1, ΔR2 = .004 for 
Step 2 (NS). RT: R2 = .02 for Step 1, ΔR2 = .004 for Step 2 (NS). a p < .05; b p < .01
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low end of the 95% confidence interval for amplitude. Older participants were defined 
as all participants from the age of 25.54, which marks the high end of the 95% 
confidence interval for latency.
In young participants, amplitude correlated significantly with false positive errors 
(r=-.106; p=.002; df=840) and false negative errors (r=-.163; p<.001; df=840) with 
small effect sizes. There were no significant correlations for latency and errors. In 
older participants a significant correlation was found between amplitude and false 
negative errors (r=-.084; p=.039; df=601) with a small effect size.
Comparison of psychophysiological and behavioral trajectories
The trajectories for reaction times, P3 latency and amplitude are presented in figure 
5. The mean number of total errors per age are presented in the same figure. As can 
be seen the points of deflection (or center of the maxima and troughs) for reaction 
times, P3 latency and amplitude occur at different ages. These points of deflection, 
or model centers, were statistically compared. There was a significant difference 
between latency and amplitude (F1,3138)=8.608; p=.003), as well as between 
latency and reaction times (F(1,3138)=46.06; p<.0001).
General discussion
Developmental trajectories of the auditory P3 across the lifespan were examined 
using a systematic review and meta-analysis of all available literature and a large 
cross-sectional dataset. The P3 component was quantified in latency and amplitude 
measures. In both studies a logarithmic Gaussian model was the best fit for (inversed) 
latency and amplitude development across the lifespan. In children latency shortens 
until a minimum is reached. After the minimum, latency gradually increases with 
aging. Amplitude increases during childhood until a maximum is reached. For the 
rest of the lifespan amplitude decreases gradually. Sex effects were significant, but 
had only small effect sizes. The separate trajectories are broadly identical for males 
and females. In addition, education neither had an effect on latency nor amplitude. 
Therefore, it is concluded that the P3 development mainly is an endogenous process 
that is probably minimally influenced by exogenous factors. 
The meta-analysis demonstrated that latency is not influenced by differences in 
paradigm parameters used. However, amplitude was affected by the number of stimuli 
presented and by the stimulus loudness. Specifically, a higher number of stimuli and 
louder stimuli were associated with smaller amplitudes. More familiar and more salient 
stimuli possibly required less cognitive resources, reflected by lower P3 amplitudes.
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A remarkable finding in both parts of this review was that the P3 amplitude reached 
its maximum significantly earlier than the P3 latency reached its trough. Moreover, as 
found in the cross-sectional study, both latency and amplitude reached the centers 
of their respective models, earlier than reaction times. These findings are graphically 
summarized in figure 2.5. We therefore hypothesize that latency and amplitude index 
different aspects of brain maturation. The P3 latency possibly indexes neural speed 
or brain efficiency. The P3 amplitude might index neural power or cognitive resources, 
which increase with maturation.
As the brain develops it becomes more efficient at information processing. Structural 
organization and development leads to more efficient neural pathways and networks; 
Myelination increases neural speed. At older age increasing P3 latency is observed, 
which is in line with a “nearly linear decline from early adulthood on measures 
representing efficiency or effectiveness of processing” as described in a review by 
Salthouse (2010) on cognitive aging 1. Therefore, the P3 latency might be an index for 
speed and efficiency of information processing in the brain. In a cross-sectional 
study using diffusion tensor MR imaging performed by Brickman et al. (2012), 
Figure 2.5   Graphical summary of the found trajectories in the cross-sectional 
dataset. Dots represent the number of errors. Error bars represent SEM.
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age-associated differences in measures of white matter coherence were examined in 
participants of 7-87 years. Figure 2.6 shows fractional anisotropy (FA), a diffusion 
tensor imaging (DTI) measure indexing myelination and organization of white matter 
bundles, across age. They visually inspected the DTI data plotted as a function of age 
to determine an approximate point of deflection at age 30 and divided their sample 
into two subgroups, younger and older than 30. They found white matter fiber tracts 
to continue developing until they reach a brief plateau, at about age 30, after which 
they begin degenerating 56. The visual resemblance of their total sample with our P3 
latency data is remarkable and suggests that myelination and P3 latency may be 
related.
As was evident from our meta-analysis, amplitude is affected by paradigm properties. 
Presumably, amplitude indexes the amount of cognitive resources a participant 
needs to allocate, to successfully perform the task at hand. In the oddball paradigm, 
after a participant gets more familiar with a stimulus, because the stimulus has been 
presented more often, fewer resources are needed to evaluate it (which is called 
Figure 2.6   Trajectory of fractional anisotropy (FA) across the lifespan. Adapted 
from Brickman et al. (2012). Data points were estimated using DigitizeIt 
1.6.1 and curve-fitted using Graphpad Prism 6.0.
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habituation). In the same way, when a stimulus is louder, it may be easier to distinguish 
from the background stimuli and fewer cognitive resources are needed. As found in 
the cross-sectional analysis larger amplitudes are associated with fewer errors by 
children performing in the oddball paradigm task, reflecting more available and more 
allocated resources.
In the first years of life, amplitude increases when quantified using an oddball task. 
Although the oddball paradigm is a relatively easy task, it might still be demanding for 
very young children, with respect to their cognitive resources, to maintain their focus 
and respond accurately, which is reflected by longer reaction times and more errors. 
During development, children gain neural capacity and use this increased capacity 
to perform better on cognitive tasks. This increase in resources is quantified by an 
increase in amplitude until about 20 years of age.
A central question is why the P3 amplitude reaches its maximum at a younger age 
than the P3 latency reaches its trough? Presumably, the increase in cognitive 
resources and the improvement in efficiency are happening simultaneously, and the 
improving efficiency and neural speed might affect the model-center for P3 amplitude. 
A more efficient brain may not have the need to substantially recruit its cognitive 
capacity, if a task can be successfully performed with only a part of the available 
resources. Indeed, a study in adults reported that in a low demand n-back task, high 
performers used fewer resources by demonstrating lower P3 amplitudes in order to 
achieve the same performance compared to the low performers 57. Until a certain 
level of efficiency is reached, a smaller proportion of cognitive resources is required 
to perform a given task. So, in young subjects, increasing brain efficiency and neural 
speed might have a moderating effect on the amplitude trajectory in which the 
amplitude model-center is shifted to a younger age.
As the myelination and organizational processes continue to progress after the 
amplitude maximum was reached and until into late adolescence, P3 latencies 
decline further, and task performance, quantified by shorter reaction times, improves 
further. The best performance is reached around the age of 30, after the optimal 
amplitude and latency were reached.
In older age, speed of processing is reduced 58 and behaviorally, reaction times are 
longer. (Subclinical) degenerative effects cause P3 latencies to increase and 
amplitudes to decrease. These aging-related degenerative effects are visible from 
neuroimaging studies as well 56,59, where changes in white matter integrity were an 
important factor in executive dysfunction in older people 56. The compensation-relat-
ed utilization of neural circuits hypothesis, or ‘CRUNCH’ model states that individuals 
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recruit additional neural activity as task load increases. The model also states that 
beyond a level of task demand, brains of older adults may reach their capacity limits 
leading to a decline in performance 5,57. Because of less efficient processing older 
people may be required to recruit additional resources at lower cognitive load levels 
than younger adults to achieve the same performance 60. These compensatory 
mechanisms may be mediated in the prefrontal cortices 61-65, which is in line with the 
anterior shift in the topography of the P3 amplitude that has been reported in older 
people 66-69. Therefore, it would be interesting to investigate both frontal and parietal 
P3 amplitude trajectories using a more cognitively challenging paradigm. Also, a 
distinction in the amplitude trajectories between high and low performers may provide 
insights into this hypothesis.
In conclusion, our findings clearly demonstrate that the P3 follows a specific trajectory 
across the lifespan reflecting brain maturation in childhood and adolescence and 
degenerative effects in older age. Although both P3 latency and amplitude can be 
fitted by a logarithmic Gaussian model, there are relative differences. Specifically, the 
centers of both models, that mark a plateau period segregating the maturation from 
degenerative effects, occur at different ages. This suggests that latency and 
amplitude reflect different aspects of brain maturation. Specifically, the P3 amplitude 
might be an index for the amount of cognitive resources being used, increasing in 
early developmental and decreasing with further aging beyond adolescence. Higher 
amplitudes are related to a higher proportion of allocated cognitive resources and 
intra-subject to improved cognitive performance. P3 latency may be a more direct 
index of information-processing speed and, indirectly, cognitive performance.
As far as we know, this study is the first to investigate the developmental trajectory of 
the P3 across the entire lifespan in a large dataset. Using advanced curve-fitting 
procedures we were able to determine ages that mark a maximum or trough 
segregating maturational from degenerative stages. The obtained trajectories are 
important because they provide new ways to compare healthy age-related maturation/
degeneration to that associated with certain disorders (e.g. dementia, ADHD, 
dyslexia, schizophrenia). 
There are some limitations to the current study. First, this study describes the 
age-related development in a large group of healthy participants. The developmental 
pattern that was found for this group cannot easily be translated to individual 
participants. There is much variation in P3 latency and amplitude between individuals, 
which makes it challenging to compare the P3 of a single participant to this model 
(albeit, this was not the primary aim of this study). Second, in the meta-analysis, 
some studies could not be included because they were not available to the authors, 
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e.g. conference abstracts, old studies. Because the amount of studies to be scanned 
was extensive we chose to include only those studies that were available online or in 
local libraries. We believe the number of included studies is sufficient by this method, 
also evidenced by the similarities in results as compared to the cross-sectional 
sample. Although the results would have been stronger if more studies could have 
been included, we do not expect the results would be different from the ones 
presented in this paper. Third, the reported P3 latencies and amplitudes were 
measured using a peak-picking method. The highest peak of a component in the 
ERP is arbitrary since it does not represent any meaningful information about this 
component. Although this method is very conventional, especially in older studies, its 
validity can be questioned. This problem is partly solved by the large datasets that 
were used in our study.
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Abstract
In the present study the frontal and parietal P3, elicited in an auditory oddball 
paradigm were investigated in a large sample of healthy participants (N=1,572), aged 
6-87. According to the concepts of the compensation-related utilization of neural 
circuits hypothesis (CRUNCH) it was hypothesized that the developmental trajectories 
of the frontal P3 would reach a maximum in amplitude at an older age than the 
amplitude of the parietal P3 amplitude. In addition, the amplitude of the frontal P3 
was expected to increase with aging in adulthood in contrast to a decline in amplitude 
of the parietal P3 amplitude. Using curve-fitting methods, a comparison was made 
between the developmental trajectories of the amplitudes of the frontal and parietal 
P3. It was found that the developmental trajectories of frontal and parietal P3 
amplitudes differed significantly across the lifespan. During adulthood, the amplitude 
of the parietal P3 declines with age, whereas both the frontal P3 amplitude and 
behavioral performance remain unaffected. A lifespan trajectory of combined frontal 
and parietal P3 amplitudes was found to closely resemble the lifespan trajectory of 
behavioral performance. Our results can be understood within the concepts of 
CRUNCH. That is, to compensate for declining neural resources, older participants 
recruit additional neural resources of prefrontal origin and consequently preserve a 
stable behavioral performance. Though, a direct relation between amplitude of the 
frontal P3 and compensatory mechanisms cannot yet be claimed.
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Introduction
The P3 complex
The event-related potential (ERP) is a waveform that is commonly determined by 
averaging brain activity in the electroencephalogram (EEG) time-locked to a specific 
event, for instance an auditory stimulus. The ERP consists of a series of components 
that can be distinguished based on their latency (ms), polarity (positive/negative), 
amplitude (μV) and scalp distribution. The P3 complex of the ERP is a large positive 
waveform that reaches its peak amplitude at approximately 300 milliseconds after 
stimulus presentation 11. An advantage of the P3 with respect to the other components 
of the ERP is its relatively large size, which makes it easy to detect. The P3 that is 
elicited in the auditory oddball consists of neural activity originating from presumably 
the prefrontal cortex, the temporoparietal junction, the primary auditory cortex and 
possibly more sources 70. In the oddball paradigm a participant is presented with two 
(or more when distracter stimuli are included) different stimuli that have to be 
discriminated. The stimuli can differ for instance in pitch, loudness, or duration, and 
are commonly presented with two different probabilities (e.g. 20% vs. 80%). The 
infrequent stimulus is generally designated as the target stimulus and participants 
are instructed to respond to this target stimulus, e.g. by a button press or by silent 
counting 10,20,21. For a schematic overview of an ERP elicited within an oddball 
paradigm see Figure 2.1 in the previous chapter. The oddball is a simple task that can 
be executed by very young children, adults and the elderly. This is an important 
advantage in aging studies that, like this paper, investigate a broad age range.
Besides numerous studies demonstrating the traditional parietal P3, which is 
associated with responding to infrequent target stimuli, another P3 peak has been 
reported. This peak has a slightly faster latency and a more anteriorly distributed 
topography, and is most pronounced in oddball paradigms that include a third 
infrequent non-target stimulus. This peak has been labeled P3a 22-25,71, and 
consequently the traditional P3 as described in the previous paragraph has also 
been labeled P3b. In a standard two-tone oddball paradigm the P3a cannot be 
identified easily and perhaps, the P3a is super-positioned on the more pronounced 
P3b wave – specifically in the frontal cortex - in participants that do not generate a 
clear P3a peak. Because in this paper the focus lies on information processing in 
general and a two-tone auditory oddball is used, whenever the term “P3” is used it 
refers to this entire P3 complex. The terms frontal and parietal are used to refer to the 
location where the P3 is measured. 
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The P3 amplitude as an index for cognitive aging
The P3 has been associated with various cognitive processes like attention, working 
memory, and executive function. One of the most prominent hypotheses linking the 
P3 amplitude to cognitive functioning is the context-updating hypothesis. This 
hypothesis states that the mental model a participant has of his/her current 
environment (context) is evaluated and updated when a relevant and deviant stimulus 
is introduced into the environment 17. However, the context-updating hypothesis is 
only one of several hypotheses aimed at explaining the underlying cognitive 
mechanisms of the P3. Others are for example, the stimulus-evaluation hypothesis 16, 
the context-closure hypothesis 18 and the attentional resource-allocation model 14. 
Recently, a robust centro-parietal positivity in an averaged ERP signal has been 
related to decision-making processes. This positivity showed a strong resemblance 
to the traditional P3 and might revitalize the idea of the P3 reflecting a decision making 
process 72-75. Another recent study hypothesized that the P3 is mainly indicating 
activation of rare stimulus-response links. Additionally, for smaller parts the P3 also 
reflects components of pure stimulus-related and pure response-related processes 
76. Although the P3 remains fairly elusive with respect to the involved cognitive 
processes, there is broad consensus that the P3 indexes aspects of cognitive 
information processing. For example, the P3 amplitude can be seen as an index for 
the amount of cognitive resources that a participant allocates in a cognitive task 14. 
Thus, with an increase in mental effort, P3 amplitude will also increase. A decline in 
P3 amplitude with increasing task difficulty has also been reported 77,78. P3 amplitudes 
are smaller when task difficulty is manipulated by increasing the similarity between 
the target and background stimulus (e.g., reducing the difference in pitch), creating 
uncertainty whether a stimulus is a target or not. Thus, in a difficult task, P3 amplitude 
increases when a participant devotes more effort to it, but decreases when the 
participant is less certain of the stimulus category 13. 
In our previous study, we modeled the developmental trajectory of the parietal P3 
amplitude measured at Pz across the lifespan in a large cross-sectional sample 
(N=1,572). Furthermore, we performed a systematic review and meta-analysis on 
lifespan changes in the parietal P3 amplitude that showed similar results as were 
found in the cross-sectional sample. The amplitude of the parietal P3 was found to 
increase during childhood to reach a maximum around the age of 21, after which it 
gradually decreased, in line with evidence on cognitive decline from early adulthood 
to old age. Despite the observed decline in P3 amplitude during adulthood, behavioral 
performance remained relatively stable until into old age. In this earlier study we 
hypothesized that there might be neural processes in older age that compensate for 
this parietal P3 amplitude decline 79. 
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Compensation from prefrontal regions
Compensatory brain activity in older age has been described in several ways. One 
hypothesis, the Compensation-Related Utilization of Neural Circuits Hypothesis, or 
”CRUNCH”, states that the aging brain recruits compensatory neural resources when 
solving a task in order to maintain the achieved output (i.e., the behavioral 
performance) at a level that is equivalent to that of a younger brain. Firstly, the aging 
brain may increase activity in a certain neural network to compensate for declining 
processing efficiency in that same network. In addition, compensation might be 
achieved by increased activity in other, yet connected networks. Thus, increasing the 
activity in a certain or alternative network may reflect compensation for reduced 
neural processing. Only once the limits of increased activation in a certain network 
and recruiting alternative neural resources are reached, task performance will decline 
5,57,80. 
Other relations between compensation and frontal brain activity have been found as 
well. Cabeza et al. (2002) compared high versus low performing old adults and 
demonstrated that the older low performers used neural networks similar to young 
participants (unilateral frontal activation), but in an inefficient manner. The old high 
performers compensated through a reorganization of neurocognitive networks 
demonstrated by bilateral frontal activation. This model was called Hemispheric 
Asymmetry Reduction in Old adults or HAROLD 63 (also see Berlingeri et al. (2013) for 
a comparison of the HAROLD model versus the CRUNCH model 81). A posteri-
or-to-anterior age-related shift in the recruitment of neural resources (Posterior-Ante-
rior Shift in Aging or PASA) has been suggested to reflect compensation for 
age-related changes in posterior regions 65. Recently this research group 
demonstrated a negative correlation between white-matter deficits and over-activa-
tion in the prefrontal cortex and medial temporal lobes in older adults that showed 
successful behavioral performance in executive function and memory tasks 82. 
Geerligs et al. (2012) observed an increased relation between inhibition inefficiency 
and phase locking in the higher beta band between frontal and occipito-parietal 
regions. High-performing older patients showed more phase locking and they 
suggested that this represented a compensation mechanism leading to more 
effective inhibition 83. Li et al. (2013) found that, during attention, older adults 
increasingly recruited neural networks that were more frontally distributed. They 
suggested this might be compensatory to age-related decreases in inhibition 
capacities 68. A recently published study using fMRI during a working memory task, 
demonstrated brain activations in the left dorsolateral prefrontal cortex related to 
aging. The nature of this relation was dependent on task load. At low task demands, 
activation in this region increased with aging, whereas at higher task demands (and 
when participants reached their capacity limits), activation in this region decreased 
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with aging. In the low task demand condition increased frontal activation was related 
to a decrease in behavioral performance, which was not in line with the concepts of 
CRUNCH. Possibly, this frontal activation in this task condition may reflect inefficient 
neural processing or failed compensation 84.
In all, when compensatory activity is based on recruitment of alternative neural 
circuits, it has been proposed that these alternative neural resources are predominantly 
recruited from prefrontal cortices. Recruiting compensatory frontal neural circuits 
seems also in line with the often reported anterior shift in P3 topography with aging 
66-69. While it remains under debate whether increased frontal activation related to 
aging is either reflecting compensatory processes or inefficient cognitive processing 
70,85, it may well be that the same neurocognitive mechanism underlies both. That is, 
when inhibitory abilities decrease with aging, increasing frontal activity may reflect 
failed or successful compensatory mechanisms in respectively low and high 
performing older participants. As Grady (2012) stated in a recent review, compensation 
may come in three forms: (1) Increased brain activation without an effect on behavioral 
performance (attempted compensation), (2) increased brain activity associated with 
improved behavioral performance (successful compensation), or (3) increased 
brain activity associated with a decline in behavioral performance (unsuccessful 
compensation). 
The present study
Assuming the P3 amplitude reflects cognitive functioning in general, it might be 
suitable as an index for neurocognitive aging. This is supported by findings from 
others, for instance Walhovd and Fjell (2001), who demonstrated that the P3, 
measured at Cz and Pz, showed strong correlations with age. Interestingly, this 
correlation was not observed for the P3 amplitude measured at Fz 29. Possibly, 
cognitive processing reflected by a frontal P3 might be different from the parietal P3. 
One of the explanations for this apparent discrepancy might lie in the concept of 
frontal compensatory brain activity. 
Since the ERP reflects cumulative neural activation related to multiple processes 
involved in stimulus processing, these parallel processes (i.e. the underlying ERP 
components) are likely to have overlapping post-stimulus latencies 13,86. Congruently, 
the P3 has been found to consist of multiple underlying independent components or 
sources. For instance, using independent component analysis (ICA), Onton et al. 
(2006) found three independent components that project to posterior cortical areas, 
and one projecting to the frontal cortical areas 87. In addition, intracranial studies, 
lesion studies and fMRI-EEG studies (see the review by 88) and analyses with Low 
Resolution Electromagnetic Tomography (LORETA) 89 point towards multiple neural 
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generators of the P3. Possibly, prefrontal compensatory mechanisms may weigh 
heavier on the P3 measured at an anterior location compared to the P3 measured at 
a posterior location. If the P3 measured at Fz consists of another source mix (in other 
words reflecting a different mixture of cognitive processes) than the P3 at Pz, and this 
source mix changes with aging, differences in developmental trajectories are to be 
expected.
In this study we aim to further test this hypothesis and firstly replicate the finding from 
Walhovd and Fjell (2001) that the frontal P3 does not decrease with age. Secondly, 
we compared the frontal and parietal P3 amplitude developmental trajectories. 
Thirdly, we investigated whether the combined parietal and frontal P3 lifespan 
trajectory is more clearly associated with the behavioral performance trajectory in an 
oddball task, as compared to separate frontal or parietal P3 lifespan trajectories. 
More precisely, it is expected that the amplitude of the frontal P3 will be lower than the 
amplitude of the parietal P3 in children. Since frontal brain structures mature relatively 
late 90,91, neural activation originating from frontal structures is lower at young age. In 
our earlier study, we observed a decrease in amplitude of the parietal P3 with aging 
79. Based on CRUNCH, we expect that, unlike the parietal P3, the frontal P3 will 
steadily increase in magnitude with advanced aging, reflecting an increase in 
recruitment of compensatory frontal neural circuits that predominantly weigh on the 
frontal P3. In short, the developmental amplitude trajectories of the frontal and parietal 
P3 are expected to be markedly different with aging. This would also indicate that a 
P3 measured only at a posterior site would be insufficient to index cognitive aging. 
A lifespan trajectory of combined frontal and parietal P3 amplitudes, reflecting 
compensated neural activity, is expected to be related more closely to behavioral 
performance. As the P3 latency may index information-processing speed 79,92, 
latencies of both the frontal and parietal P3 are expected to increase with aging 
reflecting an overall decline in processing speed.
Method
Participants
Data of individuals in the age range of 6-87 were extracted from the Brain Resource 
International Database (BRID). This database contains data from multiple laboratories 
(New York, Rhode Island, Nijmegen, London, Adelaide, and Sydney) that have been 
acquired using standardized data acquisition techniques (identical amplifiers, 
 standardization of other hardware, audio calibration, paradigm details, software 
acquisition, and task instructions). Inter-lab reliability and test-retest reliability 
measures are high and have been reported elsewhere 19,50,51. Database exclusion 
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criteria included a personal or family history of mental illness, brain injury, neurological 
disorder, serious medical condition, drug/alcohol addiction, first-degree relative with 
bipolar disorder, schizophrenia, or genetic disorder. 
The sample consisted of 1,572 participants (786 males; mean age = 27.17 ± 19.16). 
Age distributions are listed in table 3.1. For every age (e.g., 6, 7, 8, …) sex distributions 
were 50/50%. Education scores varied from 1 to the maximum score of 18 years of 
education (mean = 11 ± 4). Participants were required to refrain from caffeine and 
smoking (2 hours) and alcohol (6 hours) prior to testing. All participants gave written 
informed consent. This sample was identical to the sample used in our previous 
study 79.
Electroencephalographic data acquisition
EEG and ERP recordings were performed using a standardized methodology and 
platform (Brain Resource Ltd., Australia). Participants were seated in a sound and 
light attenuated room, controlled at an ambient temperature of 22 °C. EEG data were 
acquired from 26 channels: Fp1, Fp2, F7, F3, Fz, F4, F8, FC3, FCz, FC4, T3, C3, Cz, 
C4, T4, CP3, CPz, CP4, T5, P3, Pz, P4, T6, O1, Oz and O2 using a Compumedics 
Quick-Cap with sintered Ag/AgCl electrodes and Neuroscan NuAmps DC amplifier 
with a 100 Hz low-pass filter (range is DC-100 Hz). Data were offline referenced to 
averaged mastoids with a ground at AFz. Horizontal eye movements were recorded 
with electrodes placed 1.5 cm lateral to the outer canthus of each eye (bipolar). 
Vertical eye movements were recorded with electrodes placed 3 mm above the 
middle of the left eyebrow and 1.5 cm below the middle of the left bottom eyelid. Skin 
Table 3.1  Age distributions.
Age group N
6 to 9 118
10 to 19 704
20 to 29 246
30 to 39 126
40 to 49 100
50 to 59 116
60 to 69 96
70 to 79 62
80 to 83 4
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resistance was aimed at <5 kOhms for all electrodes. A continuous acquisition 
system was employed and EEG data were EOG corrected offline 53. The sampling 
rate of all channels was 500 Hz. 
ERP scoring
Conventional ERP averages were obtained from Fz and Pz recording sites for target 
stimuli. Only stimuli with a correct target response were included in the target average. 
Before averaging, EEG epochs were filtered at 25 Hz with a Tukey or cosine taper to 
35 Hz, above which frequency no signal was passed. For the target stimuli waveforms, 
the peak (amplitude and latency) of the frontal P3 was identified at Fz and of the 
parietal P3 at Pz. Amplitudes were defined relative to a pre-stimulus baseline average 
of -300 to 0 ms. The peaks were scored within a pre-determined latency window of 
220-550 ms.
Experimental paradigm
The oddball paradigm (figure 2.1) consisted of a quasi-random sequence of 280 
frequent background tones (500 Hz) and 60 infrequent target tones (1000 Hz). Two 
targets could not appear consecutively. All stimuli (50 ms; 5 ms rise and fall time) 
were presented binaurally (via headphones) at a volume of 75dB SPL with an 
inter-stimulus interval of 1000 ms. Participants were instructed to press two buttons 
simultaneously (one for each index finger) when they heard a target tone and to 
ignore the background tones. Speed and accuracy of response were both equally 
stressed in the instructions. Before the actual test they were presented with a brief 
practice run to clarify the distinction between the two tones.
Statistical analysis
Using Graphpad Prism 6.0, log Gaussian curves were fitted separately to amplitudes 
and (inverted) latencies of both the frontal and the parietal P3 across the lifespan. 
Curves are described by three parameters; a center value, a width value and an 
amplitude value. Center is the x value at the peak of the distribution; width is a 
measure of the width of the distribution expressed in the same units as x; amplitude 
is the height of the center of the distribution expressed in y units (www.graphpad.
com). To avoid confusion the amplitude parameter will be referred to as the ‘height’ 
of the model. The parameters of developmental trajectory models for the frontal and 
parietal P3 were statistically compared against a global model (one model explaining 
all data) by an extra sum-of-squares F test available in Graphpad Prism 6.0. The 
extra- sum-of-squares F test expresses how well one model fits the data versus 
another simpler case of the model (i.e. the global model) by comparing the difference in 
sum-of-squares between the models versus the sum-of-squares that can be expected 
by chance. The null hypothesis in this case is that the simpler global model is correct.
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Since CRUNCH is aimed at older subjects, age-effects on (1) psychophysiological 
measures, i.e. P3 amplitudes and latencies, and (2) behavioral performance were 
evaluated in a sub-group as well. Behavioral performance was defined as the reaction 
time divided by the accuracy rate (percentage of correct responses). Notice that 
larger values on this scale indicate a lower performance. The sub-group consisted of 
all participants older than 21 years. This cut-off was based on the age at which the 
parietal P3 reached its maximum amplitude and compensatory frontal activity is 
expected to start emerging. For the frontal P3 amplitude, P3 latencies (frontal and 
parietal) and behavioral performance an exponential growth model was tested; for 
the parietal P3 amplitude an exponential decay model was tested. These models 
were compared against a constrained linear model representing no age-related 
change (slope was constrained to 0). (See appendix 2 for the model equations and 
www.graphpad.com/guides/prism/6/curve-fitting for a description of the models.)
Next, another measure was evaluated: The combined P3 amplitude, defined as the 
mean of the amplitudes of the frontal and parietal P3 expressing the net recruited 
potential, was modeled by fitting a log Gaussian curve. This model’s parameters 
(center and width) and the parameters of a log Gaussian model for behavioral 
performance were statistically compared against a global model by an extra 
sum-of-squares F test. The correlation between combined P3 amplitude and 
behavioral performance was calculated post-hoc.
Because each time two aging models were compared on three parameters a 
Bonferroni corrected alpha of .0017 (initial alpha level of .01, six tests) was employed.
Results
Developmental trajectories across the lifespan
As can be seen in Figure 3.1 the developmental trajectories of the amplitudes for the 
frontal and parietal P3 are markedly different. The parietal P3 amplitude increases 
rapidly during childhood until a maximum is reached, after which it gradually 
decreases. In contrast, the amplitude of the frontal P3 reaches a plateau much later 
(at an age of 46 years) and decreases minimally. Statistical comparison of the curve 
fits for both P3 amplitudes reveals that the trajectories are significantly different 
(F(3,3081)=583.4; p<.0001). A post-hoc analysis of the separate model parameters 
(i.e. the center, width and height) shows that the models differ significantly on all of 
these parameters, see Table 3.2.
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Figure 3.1   Developmental trajectories of the frontal (Fz) and parietal (Pz) P3 
amplitude across the lifespan. Note the different trajectories of the 
frontal and parietal P3 amplitude across the lifespan, where the parietal 
P3 peaks around the age of 21 years and then shows a progressive 
decrease, and the frontal P3 peaks around the age of 46 years, showing 
a less pronounced decrease in amplitude with increasing age.
Table 3.2  Frontal versus parietal model parameters.
Center (yrs.) Width (yrs.) Height (μV/ms)
Amplitude Frontal 46.2 0.8 8.9
Parietal 21.4 1.0 16.8
p < .0001 .0005 < .0001
Latency Frontal 26.0 1.7 334.8
Parietal 24.7 1.7 342.0
p .041 .6 .0004
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As can be seen in Figure 3.2 the developmental trajectories of the latencies for the 
frontal and parietal P3 are parallel. Both show a decrease in latency during childhood 
until a minimum is reached with a center around 25 years of age, after which latency 
gradually increases with aging. Statistical comparison of both models reveals that the 
models are significantly different (F(3,3081)=11.0; p<.0001), however, this difference 
is driven solely by the height of the models, see Table 3.2. Thus, the latency of the 
frontal P3 is overall faster than the latency of the parietal P3. The trajectories in which 
they both develop across the lifespan are, in fact, very similar. (When height is not 
included in the analysis: F(2,3081)=2.2; p=.115).
Figure 3.2   Developmental trajectories of the frontal (Fz) and parietal (Pz) P3 
latency across the lifespan. Dashed lines indicate the 95% confidence 
interval. Note the similarity in developmental trajectories, with only an 
apparent overall difference in frontal and parietal latencies but not in  
its progression across the lifespan.
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Effects of aging on psychophysiological and behavioral measures
Effects of aging on psychophysiological and behavioral measures were investigated 
in participants aged 21-80 years. In this sub-group, non-linear models were compared 
to a linear model with a slope constrained to a value of 0 (i.e., a horizontal line). 
For the amplitude of the frontal P3, the exponential growth model did not significantly 
differ from the constrained linear model (F(1,686)=4.7 p=.0313). Post-hoc, an 
unconstrained linear model was compared to the constrained linear model to test 
whether amplitudes might actually be declining with aging. This analysis also 
Figure 3.3   Developmental trajectories of behavioral performance, the frontal (Fz), 
the parietal (Pz), and the combined P3 amplitude across the lifespan. 
Vertical lines indicate points of deflection in these trajectories. 
Behavioral performance is plotted on an inverted y scale. Note the 
similarity between the developmental trajectories of the combined  
P3 amplitude and behavioral performance, suggesting that behavioral 
performance is best associated with frontal and parietal networks.
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demonstrated no significant difference (F(1,686)=5.2; p=.0226). For the amplitude of 
the parietal P3, the exponential decay model explained the data significantly better 
than the constrained linear model did (F(2,710)=38.8; p<.0001; R2=.10), suggesting 
an exponential decline of P3 amplitude with increasing age. Both latencies of the 
frontal and parietal P3 were significantly better explained by an exponential growth 
model than by a constrained linear model (frontal: F(1,686)=139.3; p<.0001; R2=.17; 
parietal: F(1,711)=183.0; p<.0001; R2=.20), indicating that P3 latencies increase with 
aging (exponentially). For behavioral performance an exponential growth model did 
not statistically differ from the constrained linear model (F(1,711)=2.393; p=.122) 
suggesting that behavioral performance remains stable across time after 21 years 
of age.
Figure 3.3 shows (besides the amplitude trajectories of the frontal and parietal P3 
also) the combined P3 amplitude and behavioral performance across aging. An extra 
sum-of-squares F test of the combined P3 amplitude and behavioral performance 
models’ parameters revealed that their centers and widths were not statistically 
different (F(2,3081)=0.03; p=.97) and a global model was the best fit. The global 
center was estimated at 31 years. A post-hoc test revealed a significant correlation 
between combined P3 amplitude and behavioral performance (r=-.30; p<.0001; 
R2=.09, adjusted for age).
Figure 3.4A and 3.4B show the grand average ERPs of four age groups (i.e. 6-15, 
20-30, 35-45 and 50-60 years old) measured at Fz and Pz. These figures further 
demonstrate that aging has different effects on frontal versus parietal ERPs in adults. 
The frontal P3 amplitude and latency increase with age. As can be seen in figure 
3.4B, aging has a different effect on the posterior ERP. The P3 latency increases, but 
its amplitude decreases (in adults). It’s noteworthy that it looks like the effects are not 
restricted to just the P3. Other components, like the P2 (only anterior) and N2, also 
appear to change with aging.
Discussion
The aim of the current study was to test CRUNCH by comparing the developmental 
trajectories of the frontal and parietal P3 elicited in an auditory oddball paradigm. It 
was expected that the developmental trajectories of the frontal and parietal P3 
amplitudes would be markedly different, and that the combined frontal and parietal 
P3 would be better related to behavior as compared to either of these in isolation. No 
differences between developmental trajectories of the frontal and parietal P3 latencies 
were expected. 
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Figure 3.4   Frontal (Fz; A) and parietal (Pz; B) grand average ERPs of four age 
groups: 6-15, 20-30, 35-45, and 50-60 years old. This figure further 
visualizes the differences in how the frontal and parietal P3 are affected 
by increasing age. The frontal P3 amplitude increases with age, and  
the parietal P3 amplitude develops in a curvilinear way with age  
(an increase for children and a decrease for adults). Also note parallel 
changes on the N200 component (not investigated in this study).
A
B
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As hypothesized, trajectories of the amplitudes of the frontal and parietal P3 differed 
significantly. While we already demonstrated 79 that the amplitude of the parietal P3 
declined with aging using this sample, we here show that the amplitude of the frontal 
P3 did not increase with age, as would be expected from CRUNCH. Also, the frontal 
P3 did not decrease with age, as could be expected as a result of overall age-related 
prefrontal dysfunction. Possibly, these antagonistic effects on the frontal P3 might 
have cancelled each other out resulting in stable amplitudes across the lifespan. 
However, despite the results from the lifespan analysis, an inspection of the grand 
average anterior ERPs of three adult age groups indicates that frontal P3 amplitudes 
might subtly increase with age. The significant difference between the developmental 
trajectories of the frontal and parietal P3 amplitudes indicates that the frontal P3 
consists of other neural sources than the parietal P3 87-89, further confirmed by the 
significant difference in latency for frontal and parietal P3, which rules out volume 
conduction. This difference can be understood in terms of reciprocal compensation. 
The combined trajectory was found to be similar to the trajectory of the behavioral 
performance, suggesting it may reflect compensatory cognitive processes. 
Additionally, the correlation between the combined P3 amplitude and behavioral 
performance was highly significant and explained 9% of the variance in behavioral 
performance. Possibly, this relatively small correlation may have been due to 
increased variability in behavioral speed measures, such as reaction times, across 
the lifespan. This variability has been attributed to response-execution processes 
(and possibly response selection processes), but not to stimulus classification 92, and 
may have reduced the correlation, especially at older ages. Although latencies of the 
frontal P3 were in general shorter than latencies of the parietal P3, their lifespan 
trajectories were similar. 
The results from this study are partly in line with the CRUNCH hypothesis of 
Reuter-Lorenz and Cappell (2008). With aging, parietal neural resources diminish 
and compensatory frontal mechanisms compensate for this decline, resulting in 
stable behavioral performance. As people grow older neuroplastic processes may 
result in increased, decreased, or redistributed neural resources, and compensatory 
cognitive mechanisms may be required to optimize behavioral performance. As a 
result, it is complicated to relate the P3 amplitude to specific cognitive processes. 
The extent to which it reflects specific cognitive functions may also vary depending 
on age. That is, older people might rely more on processes reflected by the frontal P3 
to compensate for a loss in resources in neural networks that the parietal P3 reflects. 
Behavioral performance declines only when task demands require an amount of 
neural resources that exceeds the maximal resources older adults can achieve with 
neural compensation. Thus, in order to use the P3 as an index of cognitive decline not 
only the parietal P3 amplitude should be evaluated, but also the frontal P3 amplitude. 
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Adopting a lifespan approach in examining the P3 provides a unique perspective on 
understanding age-related changes in the brain. As was found in this study, the 
combination of both frontal and parietal P3 might be a good neural correlate of 
cognitive performance across the lifespan.
The observed results can be alternatively explained as the frontal P3 reflecting 
inefficient cognitive processing. As Grady (2012) stated, any (positive or negative) 
relation between aging and brain activity in frontal regions can be explained as 
compensation (successful, unsuccessful/attempted) 85. In order to substantiate the 
observed results, source analysis of the P3s at frontal and parietal regions is required. 
Here, different underlying sources for both of these measures are hypothesized. 
Another explanation for the different trajectory of the amplitude from the frontal P3 
compared to that of the parietal P3 could be found in the P3a vs P3b. Unfortunately, 
the design of the present study does not allow for a reliable quantification of the P3a, 
but it would be important to investigate the developmental trajectory of its amplitude 
across the lifespan in future studies, especially at older ages. Possibly, the P3a plays 
a significant role in altering the developmental trajectory of the frontal P3 that we did 
not observe in the present study.
There are some limitations to this study. First, the analysis consisted of comparing 
age-related trajectories of P3 amplitudes and behavioral performance (cross- 
sectional analysis). The fact that the age-related trajectories are similar does not 
necessarily mean they are causally related, since for that longitudinal studies would 
be required. Second, we did not manipulate task load in the oddball task. It would be 
interesting to compare P3 amplitude trajectories for different task loads to investigate 
frontal compensation more directly. Third, the sample in this study was also used in 
our previous study 79 and the obtained results should be replicated in an independent 
sample. However, the sample size ensures that the obtained results are reliable. 
Fourth, the reported P3 amplitudes were measured by a peak-picking method. The 
peak amplitude of an ERP component is a somewhat arbitrary measure that may not 
represent meaningful information about the component. Other methods of quantifying 
allocated cognitive resources have been proposed, for instance by determining the 
area under the curve. However, there were no task manipulations to influence 
underlying ERP components, and thereby the P3 peak, in the used oddball paradigm. 
Therefore, the peak of the P3 provides a reliable approximation of allocated cognitive 
resources in this study.
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For the purposes of indicating cognitive aging the P3 is sufficient. However, as was 
shown in the grand average ERPs in figure 5, the P3 seems not to be the only ERP 
component that changes with aging. Future studies concerning aging and ERPs 
should also include the P2 and N2. Furthermore, it would be interesting to compare 
the currently obtained developmental trajectories associated with healthy aging to 
those associated with pathological aging, such as seen in mild cognitive impairment 
or dementia. Aging-related deterioration in cognitive performance in such a clinical 
sample might be associated with a decline in parietal neural processes, lacking 
frontal compensatory processes, or both. The P3 amplitude is a solid, quick, and 
affordable measure that provides a more direct reflection of cognitive processing 
compared to behavioral measures, and that has the potential to capture these 
deficiencies.
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Abstract
Personalized medicine in psychiatry is in need for biomarkers that resemble CNS 
function at the level of neuronal activity. Electroencephalogram (EEG) during sleep or 
resting state condition and event-related potentials (ERP) have not only been used to 
discriminate patients from healthy subjects but also for the prediction of treatment 
outcome in various psychiatric diseases, yielding information about tailored therapy 
approaches for an individual. This review focuses on baseline EEG markers for two 
psychiatric conditions, namely major depressive disorder (MDD) and attention deficit 
hyperactivity disorder (ADHD). It covers potential biomarkers from EEG-sleep- 
research and vigilance-regulation, paroxysmal EEG patterns and epileptiform 
discharges, qEEG features within the EEG-main frequency bands, connectivity- 
markers and ERPs components that might help to identify favourable treatment 
outcome. Further, the various markers are discussed in the context of their potential 
clinical value and as research domain criteria, before giving an outline for future 
studies that are needed to pave the way to an electrophysiological biomarker-based 
personalized medicine.
65
AN OVERVIEW OF THE ROLE OF EEG/ERP IN PERSONALIZED MEDICINE
4
Genetics, endophenotypes and biomarkers
In some fields of medicine, individualized and personalized treatment has become 
state of the art. Especially in oncology, the assessment of individual biological 
properties of the patient and the cancer cells helped to make treatment more efficient, 
reduce side effects and improve secondary prevention strategies 93. The paradigm- 
shift from standard ‘one-size-fits-all’ treatment plans according to descriptive markers 
such as stage and locus of the cancer to individual therapy algorithms based on e.g. 
genetic markers is thought to be of value also for neuropsychiatric disorders and 
raises new hopes for tailored therapies in psychiatry. However, a mental disorder is 
completely different from a well observable and definable solid tumor: There is no 
clear organic correlate that is responsible for the symptoms, instead multidimensional 
and possibly very heterogeneous alterations of brain function sum up to the clinical 
syndrome. 
Although psychiatric disorders such as major depressive disorder have an assumed 
high heritability of up to 37% 94, large scale genome wide association studies (GWAS) 
have thus far failed to link genetic variants with major depressive disorder 95. This 
underpins the suggested polygenetic nature of psychiatric disorders 96 and implies 
the need for endophenotypes that are seen as an intermediate step between genotype 
and behaviour. Endophenotypes are more closely related to genotype than behaviour 
alone and may be a possible way to stratify a population for GWAS 97. Although some 
promising findings using different sets of clinical and neuroimaging endophenotypes 
in major depression have been reported 98, a recent study on psychophysiological 
endophenotypes can be seen as a drawback to this approach since the authors were 
unable to replicate significant associations between endophenotypes and candidate 
genes 99.
Given that the link between endophenotypes and genetics might not be that strong 
or simple as suggested, an association between endophenotypes and disorder 
might still be present and could help to improve treatment and diagnostic decisions. 
In this context the term „biomarker“ seems relevant; that is according to the National 
Institutes of Health (NIH) „A characteristic that is objectively measured and evaluated 
as an indicator of normal biologic processes, pathogenic processes or pharmacologic 
responses to a therapeutic intervention“ 100. The value of a personalized medicine 
approach is not determined by the association of a marker with genetic variants but 
by the improvement it yields for the diagnostic process (by making it more objective) 
and, probably more important, by the increased effectiveness of the treatment (i.e. 
a more prognostic biomarker). As Thomas Insel, director of the NIMH stated “The task 
is to identify the biomarker that predicts response—whether the treatment is a 
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medication or a psychosocial intervention.” The first step towards this “precision 
medicine” development was the introduction of the Research Domain Criteria (RDoC) 
project which is aimed to transform clinical syndrome-based diagnosis into an 
individualized framework of psychophysiology to support the diagnostic process of 
mental disorders 101 and -hopefully- improve treatment. Currently several large scale 
studies are ongoing that should be able to shed more light on this development, such 
as the international Study to Predict Optimized Treatment Response (iSPOT) in 2016 
patients with MDD and 672 children and adolescents with ADHD (also see: 102 for 
further protocol details) and the EMBARC study (Establishing Moderators and 
Biosignatures of Antidepressant Response for Clinical Care for Depression: https://
clinicaltrials.gov/ct2/show/NCT01407094).
Electroencephalogram and Biomarkers
Sparked by the discovery that the mode of function of the human central nervous 
system is based on electric activity 103,104, the invention of the electroencephalogram 
(EEG) and its first description in humans 6 provided the possibility to analyse the brain 
at its core functional level. Taken as a tool for assessment for biomarkers, that, 
according to the definition, should be assessable objectively and provide information 
about physiological or pathological processes or responses to treatment interventions 
105, the EEG also fulfils the criteria of a cost efficient, nowadays broadly available and 
already established tool in the diagnostic clinical practice. Further, the EEG captures 
ongoing neuronal activity with a temporal resolution that surpasses any other 
neuroimaging modality such as functional magnetic resonance imaging (fMRI) or 
positron emission tomography (PET). Also, the EEG is not a surrogate marker of 
neuronal activity (such as the blood deoxygenation level dependent signal in fMRI or 
the glucose utilisation in PET, see 106) but is a direct reflection of neuronal activity 
(post-synaptic potentials, PSP) 107. It is therefore highly plausible that a personalized 
medicine approach in psychiatry could gain from electrophysiological markers. 
Although electrophysiological biomarkers have been studied throughout many 
psychiatric disorders, the current review is dedicated to only two of them: major 
depressive disorder (MDD) and the attention deficit-hyperactivity disorder (ADHD). 
The following work describes the current state of the art of baseline EEG parameters 
by means of their diagnostic and predictive (prognostic) value. Treatment emergent 
biomarkers that yield information about changes in the early course of treatment will 
not be subject of the review and the interested reader is referred to Olbrich and Arns 
108 or Arns and Olbrich 109 for more coverage of those.
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Biomarkers
EEG-Sleep-Research
EEG biomarkers in sleep are robust and their advantage can be found in the link 
between clinical symptoms such as sleep initiation problems, early awakening or 
disrupted sleep in both, MDD and ADHD and electrophysiological assessable 
parameters. In MDD, the most consistently reported findings include a disturbed 
sleep architecture, comprising an increased rapid eye movement (REM) density 110,111, 
decreased rapid eye movement sleep (REM sleep) latency 112,113 and altered slow 
wave sleep (SWS) in MDD 114,115. 
While slow wave power seems to have a discriminative value between MDD and 
healthy controls (HC) 114,116, a predictive value for recurrence of depressive symptoms 
was found for decreased SWS, decreased sleep efficiency and delayed sleep onset 
117-119. Also the slow wave activity (SWA) itself seems to be important for treatment 
prediction. Luthringer et al. 120 reported increased relative delta power in sleep 
EEG-recordings in responders to antidepressant treatment although others failed to 
replicate these findings 121,122. Still, Nissen et al. 122 reported decreased SWA in 
responders, expressed in a high delta sleep ratio (DSR), a finding that again could 
not be replicated by Argyropoulos 123. Besides classical sleep EEG parameters, also 
a decreased coherence within the beta, delta and theta band in sleep EEG predicted 
non-response in adolescents and the occurrence of depressive episodes 124.
In ADHD there is a clear lack of studies that examine EEG-derived sleep parameters, 
although other measures such as actigraphy and salivary melatonin measurements 
suggest a delayed sleep onset in a majority of children and adults with ADHD, also 
termed sleep onset insomnia 125-127 characterized by a delayed melatonin onset. This 
delayed sleep onset results in reduced sleep duration - and thus chronic sleep 
restriction - in ADHD, which becomes visible as the typical drowsiness patterns that 
can be observed in the EEG such as impaired vigilance (see “EEG-Vigilance”) or 
excess theta (see “Frequency specific biomarkers: Theta”), for review also see 126,128.
EEG-Vigilance
Another possible EEG-biomarker that has proven its value for differentiating between 
patients suffering from MDD and HC is EEG-vigilance regulation. Hegerl 129 and 
Olbrich 130 reported that MDD is associated with an increased EEG-vigilance during 
rest with less and slower declines to lower vigilance stages during a 15 minute resting 
condition. The appeal of this marker reflecting a high tone of CNS-arousal can be 
found in the linkage between clinical symptoms and EEG-parameters of wakefulness 
regulation. A hyper stable vigilance regulation in MDD is interpreted as an electro-
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physiological correlate of the often reported sleep-problems. Increased vigilance 
further might explain the behavioural withdrawal of patients suffering from MDD to 
avoid further increase of arousal 131.
The EEG-vigilance framework further suggests that a fast decline of EEG-vigilance 
during rest might result in increased sensation seeking and hyperactive behaviour to 
stabilize wakefulness regulation. Hegerl and Hensch (2014) suppose that not only 
manic patients 132 reveal unstable EEG-vigilance regulation patterns but also patients 
suffering from ADHD 128,133. In line with this, increased theta power as a marker of 
drowsiness has been frequently reported in patients with ADHD 134 and as described 
above the majority of patients with ADHD exhibit sleep onset insomnia 125,127,128, further 
supporting this notion. However, a recent meta-analysis also suggested increasing 
levels of theta for healthy children and stable levels for ADHD children across the last 
10 years 135, suggesting a possible gene X environment (sleep, circadian clock) 
interaction for this measure requiring further research.
Paroxysmal patterns and epileptic discharges
Unlike in neurology, there are no distinct “graphoelements” in EEG recordings that 
are pathognomonic for a psychiatric syndrome. However, already in 1939 it was 
demonstrated that during subclinical epileptiform activity patients had slower reaction 
times, while others did not respond at all 136, suggesting that paroxysmal activity in 
‘non-epileptic patients’ can have behavioural consequences.
The occurrence of paroxysmal EEG in affective disorders has not been investigated 
in much detail, but previous analyses suggest a prevalence of 3-5% in depression 137 
to 20-40% in affective disorders, mostly mania 138. The 3-5% in depression is 
comparable to the 1-6% prevalence of paroxysmal EEG in normal populations 138-141. 
On the other hand, the occurrence of paroxysmal patterns in ADHD has been 
estimated to be between 12-15% 142-144 to approximately 30% 145, which is relatively 
high, compared to normal populations. A more recent study found epileptiform 
discharges in 25% of children with suspected ADHD 146.
The implications for treatment in psychiatric patients with paroxysmal patterns or 
epileptiform discharges - but without a history of seizures - remain unclear. It is still 
remarkable that several studies found that ADHD patients 147-149 do respond to 
anticonvulsant medication, e.g. to carbamazepine 150. Furthermore, there is some 
evidence that antidepressant treatment augmentation with antiepileptic drugs is 
effective in treatment resistant MDD 151,152 although data about the association of 
response and epileptiform discharges are lacking. As a further example, previous 
studies have demonstrated an association between paroxysmal EEG activity and 
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panic attacks (reviewed in 153,154). Patients with panic disorder and epileptiform 
EEG-patterns have been found to clinically respond to anticonvulsants 155, thus 
suggesting that there could be a subgroup of psychiatric patients in whom 
paroxysmal/epileptiform EEG activity could be associated with their psychiatric 
complaints and for whom anticonvulsant treatment could be a choice for augmentation 
of treatment or as standalone treatment. However, this requires further controlled 
research.
Frequency specific biomarkers: Alpha
One of the most prominent features of a resting state EEG is the EEG-alpha activity 
with heritability estimates of up to 79% 35. Alpha in adults has a mean frequency 
around 10Hz with a range between 7-13 Hz and has maximum amplitudes at parie-
to-occipital locations in eyes closed condition. 
In MDD a consistent finding is an elevated absolute 156-160 or relative alpha power 161,162 
at mainly parietal and frontal 158,163 or occipital sites 164. The reason that some studies 
did not find alpha power differences between patients and healthy controls 165 or 
found decreased (relative) alpha activity in comparison to other patient groups 
166might be related to differences of recording periods, where shorter recording 
periods prevent the above described 129,130 differences in vigilance regulation to occur 
(e.g. 6 min in 165 versus 15 min in 129,130. 
In addition, there is some evidence, that EEG-alpha power can predict treatment 
outcome with low parieto-occipital 164,167,168 or lowered frontal alpha power 169 
associated with non-response to antidepressants, although this could not be 
replicated in the recent multicentre iSPOT-D study in 1008 MDD patients 170. However, 
for treatment with repetitive transcranial magnetic stimulation (rTMS), the opposite 
was reported 168,169 maybe related to higher levels of treatment resistance in these 
rTMS studies. 
EEG-alpha asymmetry has been investigated as a biomarker for MDD with a 
decreased alpha power at right frontal sites relative to the left side 171-174 although 
many studies have failed to replicate these findings 170,175-179. Interestingly in ADHD, 
Keune et al. 180 found the opposite pattern of alpha asymmetry with increased right 
frontal alpha power.
Two studies by the same group investigated the prognostic value of alpha asymmetry 
in MDD and found conflicting results 164,181, however, in the iSPOT-D study it was found 
that frontal alpha asymmetry (right frontal alpha dominance) was specifically related 
to response to the SSRI’s escitalopram and sertraline, but not to the SNRI venlafaxine 
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in females only 170, underscoring the importance of large samples that allow testing 
for gender and drug-class specific predictors of treatment outcome. 
A slow background rhythm, also called a slow alpha peak frequency (APF) has been 
consistently found a predictor for non-response to several treatments such as 
stimulant medication in ADHD 52, rTMS in depression 182,183 and the antidepressants 
pirlindol and amitriptyline 168, for review see Arns 184.
Frequency specific biomarkers: Theta
Several studies have reported elevated slow wave activity in MDD 159,185-188, with the 
focus of this elevated theta-activity localized to frontal areas and often to the anterior 
cingulate cortex (ACC) 158,188,189, though decreased ACC activity in MDD has also been 
reported 190 and some studies found no differences between MDD and controls 191,192. 
High frontal theta has been associated with non-response to antidepressant 
treatments 183,193,194 while Cook et al. 195 found no differences. Seemingly contrary to 
this, Spronk et al. 196 reported that low theta at the frontal midline was associated with 
non-response. Note that 183,193,194 all reported on widespread frontal (not midline) 
theta, most likely a reflection of ‘drowsiness’ theta as discussed above (see “EEG-
Vigilance”) on vigilance 128, whereas Spronk and colleagues found the opposite 
pattern for frontal midline theta. This suggests these two types of theta could have 
different implications and different origins. In line with 196 several studies have indeed 
shown low theta localized to the ACC, as estimated by source localization techniques, 
to respond worse to various antidepressant treatments 197-200. These findings are in 
line with positron-emission-tomography (PET) and functional magnetic-reso-
nance-imaging (fMRI) studies demonstrating low metabolic activity in the ACC is 
associated with worse treatment outcome, also see Pizzagalli 201 for an excellent 
review and meta-analysis on the rostral ACC and treatment outcome. Contrary to this 
notion, several groups have reported high perfusion in the subcallosal cingulate 
(SCC; in earlier work this area was also referred to as rACC) or rACC for non-responders 
202,203, also reviewed in 188. In line with this, recent results of the iSPOT-D study reported 
increased rACC and frontal theta to be associated with non-response, albeit with a 
small effect size 188. Interestingly, these results tended to be driven mostly by treatment 
resistance, suggesting that future studies should also investigate the role of treatment 
resistance for the association of rACC / SCC perfusion and treatment outcome 188. 
Conversely, Deep-Brain Stimulation (DBS) targeting the SCC in treatment resistant 
MDD patients has been shown to result in clinical benefits 204, positing this area, as a 
critical node in the depression network. However, the exact direction of these findings 
(high or low frontal midline theta) and exact localization (rACC vs. SCC) remains 
unclear from these lines of research, and future studies might shift the focus on 
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investigating the connectivity of this specific area with other structures rather than 
focusing solely on EEG theta power given the above contradictory findings.
In ADHD, excess theta compared to controls is an often-reported finding, sometimes 
also expressed in the Theta/Beta ratio (TBR) 134 and several reports have termed the 
TBR a solid biomarker to identify ADHD. These findings resulted in this measure 
being FDA approved as a ‘diagnostic test’ for ADHD (for commentary see 205). 
However a recent meta-analysis could not confirm that this metric is a reliable 
‘diagnostic test’ for ADHD 132, due to an increased TBR across the last 10 years for 
controls, suggesting that this marker is a non-specific marker for drowsiness, and 
insufficient as a diagnostic biomarker for ADHD. Apart from the diagnostic use, this 
metric does hold potential as a prognostic biomarker being able to predict treatment 
outcome. A substantial proportion (26-38%) of ADHD subjects did have a high TBR 
and excess theta and these subgroups have been found responders to stimulant 
medication 52,169,206 and neurofeedback 183,207, making this measure more likely a 
prognostic but not diagnostic measure 205, albeit still requiring further replication. 
Frequency specific biomarkers: Beta
In MDD there is some evidence for increased beta EEG activity 186,208. The predictive 
value for treatment outcome has not been investigated systematically so far. 
In ADHD there is evidence for a sub-group of ADHD patients that are characterized 
by excess beta or beta spindles that make up 13-20% 209-211. Several studies 
demonstrated that this subgroup does respond to stimulant medication 212-214. A 
recent study, further demonstrated that spindling excessive beta is a result of 
sleep-maintenance problems and thus can indeed be considered a ‘sub-vigil’ beta 
state, and is specifically associated with impulse control problems, irrespective of 
diagnosis 215. This would make the effectiveness of wakefulness promoting drugs 
plausible in these patients.
EEG-connectivity measures
First reports of altered connectivity in MDD in contrast to HC stem from findings of 
altered coherence between EEG-electrode sites 216,217. More recent studies used a 
huge variety of connectivity measures like partial directed coherence, granger 
causality, structural synchrony index and phase synchrony index. Some found 
decreased EEG-connectivity in MDD 208,218-220 while others report of increased 
EEG-connectivity in MDD, mainly in the alpha band 221-224. More studies are needed 
to disentangle the complex relationship between the different connectivity measures 
and their physiological interpretation and to estimate the value for treatment 
prediction. In this context, one study 224 found an association between increased 
72
CHAPTER 4
phase connectivity in the beta band between the subgenual prefrontal cortex and the 
right medial frontal cortex and treatment response. As suggested above in relation to 
theta, these approaches, when replicated could further shed light on the controversy 
between increased or decreased metabolism in the rACC/SCC.
Also in ADHD there is increasing evidence, that EEG-based measures of connectivity 
could be used to differentiate between patients and HC. Interestingly, most studies 
find increased measures of coherence especially within the beta and theta band 
during the resting state 225-227. Also graph-theory network parameters seem to support 
an increased functional connectivity in ADHD 228. Regarding a possible predictive 
value of connectivity measures, Dupuy 229 describes an association between intra-
hemispheric coherence in the beta band and response to methylphenidate. These 
findings are promising and possibly pave the way for improved differential diagnosis 
and consecutive treatment. 
Event-related potentials
The event-related potential (ERP) is a waveform of averaged EEG activity, time-locked 
to a stimulus in a cognitive task. Several components of this ERP have been studied 
for their predictive value in treatment outcome. 
In MDD research the main focus has been on two measures, namely the P3 11 and the 
loudness dependence auditory evoked potential (LDAEP), which is a derivative of the 
N1/P2 amplitude and its changes with increasing stimulus intensity 230. So far, 
research involving the P3 has been ambiguous. Jaworska and colleagues found that 
responders to antidepressants have larger P3 amplitudes than non-responders 231. A 
similar finding was reported by Bruder and colleagues for the P3 amplitude at 
occipital sites 232. In contrast, responders to treatment with rTMS were found to have 
lower P3 amplitudes than non-responders, although this effect was limited to Pz and 
only marginally significant 183. Regarding P3 latency, the results have been mixed as 
well, where some found no effect 231, while other studies found slower P3’s in 
non-responders 233-235.
The LDAEP has proven to be a more robust predictor for antidepressant treatment 
response. A strong LDAEP, i.e. a steeper increase with stimulus intensity, is supposedly 
indicative of a low level of serotonergic activity 230,236 and is related to better outcome 
to an SSRI 237, whereas the effect is reversed for responders to noradrenergic antide-
pressants 198,238,239. A recent study, however, failed to replicate this relation between 
LDAEP and treatment outcome, even though, a relation between treatment response 
and current source densities of the N1-LDAEP was obtained 240. Related to this 
measure, Spronk and colleagues found that a larger (more negative) N1 amplitude 
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was related to a larger reduction of depressive symptoms after treatment with antide-
pressants 196.
In ADHD, ERP components have also been investigated as predictors for treatment 
response to stimulants. Sangal and colleagues found the topography of the P3, 
specifically the right fronto-central to parietal amplitude ratio, to be predictive of 
response to various stimulants, i.e. methylphenidate 241, atomoxetine 242 and pemoline 
243. They also reported a study in which poor responders to pemoline were treated 
with the antidepressant imipramine. Within this sub-group, poor responders to 
imipramine demonstrated slower P3 latencies 244. Sunohara et al. could not replicate 
ERP P3 and N2 latencies as baseline predictors for treatment outcome in ADHD 
children but found some treatment emergent effects 245 which are in agreement with 
Winsberg et al. 246.
Summary
Sleep-EEG parameters have been found to be of discriminative and predictive value, 
especially in MDD. A widespread clinical use might be dampened due to the relatively 
large subject burden, e.g. one night at a sleep laboratory or even two to rule out 
first-night effects from findings 247. In ADHD, there is a lack of studies that analyse 
EEG-sleep parameters although an association of the disorder with sleep-wake cycle 
and especially circadian alterations are evident.
EEG-vigilance measures seem to provide a less cost and effort intensive approach to 
assessing wakefulness-regulation during rest in contrast to polysomnography. 
Another advantage of EEG-vigilance based markers can be found in its association 
with clinical features of MDD and ADHD as outlined above. A biomarker that has a 
direct link to the behavioural level is more likely to be accepted in clinical routine. Still, 
there is a clear lack of controlled studies that demonstrate the discriminative value of 
EEG-vigilance parameters for response or non-response in MDD and in ADHD.
For patterns of paroxysmal or epileptiform activity it remains unclear, if treatment or 
augmentation with antiepileptic drugs such as valproate, or some specific antide-
pressants increase response rates in these MDD or ADHD subgroups. Some 
evidence exists that non-responders to first line treatment may benefit. Studies that 
analyse treatment of MDD or ADHD with antiepileptic drugs should report on 
subgroups based on the occurrence of pathological but subclinical EEG patterns in 
the future.
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Several qEEG markers, especially within the alpha and theta range, revealed a 
discriminative value regarding treatment outcome. However, findings in this field are 
often contrary to what might be explainable by the variance of studied patient groups 
(treatment resistant or not) and not at last by the different treatment approaches that 
have been studied. Further, methodological and interpretation aspects need to be 
clarified as it is the case with the difference between diffuse frontal theta vs frontal- 
midline theta in MDD. Based on the existing findings, qEEG measures of the alpha, 
alpha asymmetry and theta frequencies deserve to be in the main focus in future 
studies of treatment prediction. 
EEG-connectivity analysis has seen a revival within the past few years and first 
findings seem to be promising with regard to its value for treatment prediction. 
However, the used measures differ broadly; there is almost no study that uses the 
same measures for assessment of network-interaction and connectivity. Therefore 
the studies are hardly comparable. Further, many studies on EEG-connectivity do not 
make a-priori hypothesis about alterations of connectivity between brain regions, 
resulting in a high number of tests that analyse every possible connectivity pattern, 
possibly resulting in type-I errors. Identification of the most reliable and valid 
connectivity parameters and application on hypothesis driven, predefined networks 
should be among the first goals of future research in this field. 
Not only spontaneous EEG activity, but also event-related potentials hold value for 
the improvement of treatment. However, as it is the case in many resting-state EEG 
markers, there are promising markers that sometimes could not be replicated in 
small-scale studies. Therefore, larger study groups and controlled trials are needed 
to estimate the full potential of ERPs.
Since the aim of a personalized medicine approach is to improve treatment of the 
individual, studies are needed that analyse the predictive value of CNS-arousal in 
patients for treatment outcome. Currently, data from the iSPOT and EMBARC trials in 
MDD are being analysed using this approach.
It should be noted that personalized medicine with a focus on treatment prediction is 
in need for addressing inter-individual variance, which is in contrast to the search for 
biomarkers that reflect homogeneous diagnostic groups. Therefore, the mentioned 
differences in findings, sometimes even contrary to one another when looking at 
predictive markers for treatment response, might yield important information about 
different treatment options: it is possible that a marker predicts response to one 
treatment while it also could be found in non-responders to another treatment. 
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The goal will be to disentangle these relationships with standardized and controlled 
trials, including a variety of treatment arms and by embracing heterogeneity. 
Perspectives
The RDoCs provide a good framework to overcome subjective decisions in the 
treatment of psychiatric disorders and might help to bridge the gap to the advances 
made in medical treatment in other domains of medicine. In face of the myriads of 
available EEG-based parameters it seems obvious that there will not be one single 
marker that fulfils all criteria to aid in the diagnosis and even predict treatment in 
different neuropsychiatric disorders. It will require combining a set of neurophysiolog-
ical but also clinical and other biomarkers to fulfil the promise of a personalized 
medicine approach. Simulations on existing datasets and probably the usage of 
non-linear methods such as artificial networks could help in the analysis of large data 
matrices to extract meaningful combinations for treatment prediction 183. It should be 
noted that the goal is not a final threshold or combination of biomarkers for prediction 
but a matrix of meaningful parameters that should be subject to further refinements. 
Furthermore, one fundamental problem to be faced is that of defining clinically 
meaningful treatment endpoints. Several different primary outcome measures have 
been used ranging from the BDI-II to Hamilton Depression Inventory, and also using 
different criteria such as remission or response, whereas the agreement between 
these scales is far from perfect 248, thus making the ‘ground-truth’ of ‘clinical response’ 
a moving target dependent on the instruments and definitions used.
In the first place it is now necessary to initialize biomarker-guided treatment decisions 
that lead to increased remission rates in comparison to treatment as usual. 
Furthermore, in MDD one faces the huge variety of treatment options, ranging from 
psychotherapy with different branches, over psychopharmacological interventions 
with completely different modes of action to brain stimulation methods such as 
transcranial magnetic stimulation (TMS) or electro-convulsive therapy (ECT) but also 
sleep deprivation. In face of the high non-response rates a framework is urgently 
needed including different biomarkers that allow for an evidence based choice of the 
right treatment option at the right time for the right patients. Preferably markers should 
be taken into account that can be interpreted in the context of their physiological 
meaning since this will increase the acceptance of a marker by clinicians. Furthermore, 
as mentioned above on alpha asymmetry, large sample sizes are required to also 
address gender, age and drug-class specific predictors. Therefore, large multicentre 
studies for identification of those markers and their thresholds to predict treatment 
outcome have to be carried out, as is the case with the iSPOT-D and EMBARC 
76
CHAPTER 4
studies. The next step then will be to initiate prospective randomized controlled trials 
that compare the biomarker based treatment versus treatment based on therapist 
and patient preferences as it is currently good clinical practise. This way, personalized 
medicine could help to apply the already existing treatment options in a hopefully 
more effective and efficient way and thereby, decrease the individual burden of 
disease for patients.
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Abstract
It is essential to improve antidepressant treatment of major depressive disorder 
(MDD) and one way this could be achieved is by reducing the number of treatment 
steps by employing biomarkers that can predict treatment outcome. This study 
investigated differences between MDD patients and healthy controls in the P3 and N1 
component from the event-related potential (ERP) generated in a standard two-tone 
oddball paradigm. Furthermore, the P3 and N1 are investigated as predictors for 
treatment outcome to three different antidepressants.
In the international Study to Predict Optimized Treatment Response in Depression 
(iSPOT-D) - a multi-center, international, randomized, prospective practical trial - 
1008 MDD participants were randomized to escitalopram, sertraline or venlafaxine-
XR. The study also recruited 336 healthy controls. Treatment response and remission 
were established after eight weeks using the 17-item Hamilton Rating Scale for 
Depression. P3 and N1 latencies and amplitudes were analysed using a peak-picking 
approach and further replicated by using exact low resolution tomography (eLORETA).
A reduced P3 was found in MDD patients compared to controls by a peak-picking 
analysis. This was validated in a temporal global field power analysis. Source density 
analysis revealed that the difference in cortical activity originated from the posterior 
cingulate and parahippocampal gyrus. Male non-responders to venlafaxine-XR had 
significantly smaller N1 amplitudes than responders. This was demonstrated by both 
analytical methods. Male non-responders to venlafaxine-XR had less activity 
originating from the left insular cortex.
The observed results are discussed from a neural network viewpoint.
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Introduction
The World Health Organization (WHO) has ranked major depressive disorder (MDD) 
as the leading cause of disability worldwide 249. Individual responses to antidepres-
sants vary which often leads to the need to try different types of medication using a 
‘trial-and-error’ approach. The STAR*D trial 250,251 demonstrated that this stepwise 
approach left one third of patients resistant to treatment after being randomized to 
three different treatments, also with different modes of action. This is not sufficiently 
effective and it is essential to improve antidepressant treatment response in MDD. 
One way this could be achieved is by reducing the number of treatment steps and 
guiding the right patients to the right treatment using biomarkers. This is referred to 
as ‘personalized medicine’ or ‘precision medicine’. 
Treatment prediction employing event-related potentials
A potential predictor for treatment outcome lies in MDD patients’ electrophysiological 
properties. The event-related potential (ERP) is a waveform in brain activity that is 
time-locked to an event, for instance an auditory stimulus. Some of the ERPs’ 
components have been studied for their predictive value in antidepressant treatment 
response, where most research has been focused on the P3 (P3) and N100 (N1) (for 
review see: 108,109). 
The P3 consists of neural activity originating from several origins, including 
presumably the prefrontal cortex, the temporoparietal junction, the primary auditory 
cortex and possibly other sources 70. The P3 can be measured across the scalp, but 
he P3 measured at a frontal electrode site does not necessarily reflect the same 
cortical activation as the P3 measured at a posterior site. For older participants, 
compensatory activation from frontal regions may be involved which may be 
represented by the frontal P3 and not the parietal P3 79.
Most studies, but not all, have found lower P3 amplitudes in MDD patients compared 
to healthy controls. Some studies reported only non-significant trends of reduced P3 
amplitudes in MDD patients 252.
So far, research on antidepressant treatment response involving the P3 has been 
ambiguous. There are studies that found responders to antidepressants having 
larger P3 amplitudes than non-responders 231,232. In contrast, responders to treatment 
with repetitive Transcranial Magnetic Stimulation (rTMS) were found to have lower P3 
amplitudes than non-responders, although only marginally significant 183. Regarding 
P3 latency, the results have been mixed as well. Some found no effect of P3 latency 
231, while other studies found slower P3’s in non-responders to antidepressants 233-235.
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Spronk and colleagues found that a larger N1 amplitude at baseline (assessed in an 
oddball paradigm) was associated with better antidepressant treatment outcome 196, 
suggesting that maybe the oddball N1 amplitude could serve as a predictor to 
treatment outcome, possibly in line with earlier research implicating the N1 component 
of the Loudness Dependent Auditory Evoked Potential (LDAEP) in prediction of 
treatment outcome (see 108,253 for review).
In this study we used data from the multi-center, randomized, prospective open-label 
international Study to Predict Optimized Treatment Response in Depression (iSPOT-D) 
(see Williams et al. 102 for details). The aim of this study was to investigate differences 
between MDD patients and healthy controls in the P3 and N1 component from the 
ERP generated in a standard two-tone oddball paradigm. Furthermore, the P3 and 
N1 were investigated for their predictive power of antidepressant treatment response. 
In addition, we tested if P3 and N1 measures can aid in differential prediction to the 
three medication types. We expected to find (1) reduced P3 amplitudes in MDD 
patients, (2) larger P3 amplitudes in treatment responders compared to 
non-responders and (3) larger N1 amplitudes in treatment responders compared to 
non-responders. In our analysis we have first used a traditional peak-picking method 
to quantify the ERP components and also obtain latencies for all components. In 
addition, we have applied a time-based analysis using eLORETA to replicate the 
findings obtained from the peak-picking method and to also obtain localizations of 
the observed effects.
This study is among one of several planned iSPOT-D studies that were approved by 
the iSPOT-D publication committee. Other planned analyses on EEG metrics are 
reported in separate manuscript such as for example Arns et al. (2015) in this journal, 
for an investigation of the role of frontal and rostral anterior cingulate theta EEG power 
in antidepressant treatment prediction. 
Experimental procedures
Design
Data from this study come from the iSPOT-D study, which is an international 
multi-center, randomized, prospective open-label phase IV clinical trial. MDD patients 
were randomized to escitalopram, sertraline or venlafaxine-XR in a 1:1:1 ratio. The 
study was designed to approximate real-life treatment of MDD and therefore no 
placebo condition was included. A complete description of the study has been 
published earlier 102.
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Participants and treatment
There were 1008 MDD patients and 336 healthy controls (HC) included in this study. 
All participants were aged 18-65 years. MDD patients were treatment-naïve or 
medication was washed-out (5 half-lives). At baseline, a primary diagnosis of unipolar, 
non-psychotic MDD was confirmed by administration of the Mini-International Neuro-
psychiatric Interview 254 according DSM-IV criteria and a score ≥16 on the Hamilton 
Rating Scale for Depression (HRSD17). The visit consisted of questionnaires, an EEG 
assessment, a neuropsychological battery and a blood draw. After the baseline visit, 
MDD patients were randomized to one of the three antidepressants and a follow-up 
visit was scheduled after eight weeks. All baseline tests, except for the blood draw 
and the diagnostics, were repeated at the follow-up visit. Although this study only 
includes data from the baseline and week 8 visits, participants were in fact followed-up 
for one year in total.
This study was approved by the institutional or ethics review boards at all of the 
participating sites. This trial was registered with ClinicalTrials.gov. Registration 
Number: NCT00693849; URL: http://clinicaltrials.gov/ct2/show/NCT00693849.
Electroencephalographic data acquisition
EEG recordings were performed using a standardized methodology and platform 
(Brain Resource Ltd., Australia). Details of this procedure have been published 
elsewhere 52,102 and details of the reliability and across-site consistency of this EEG 
procedure have been published19,50. In summary, participants were seated in a sound 
and light attenuated room that was controlled at an ambient temperature of 22°C. 
EEG data were acquired from 26 channels: Fp1, Fp2, F7, F3, Fz, F4, F8, FC3, FCz, 
FC4, T3, C3, Cz, C4, T4, CP3, CPz, CP4, T5, P3, Pz, P4, T6, O1, Oz and O2 (Quikcap 
with sintered Ag/AgCl electrodes; Neuroscan NuAmps DC amplifier; extended 10-20 
electrode international system). Data were offline re-referenced to averaged mastoids 
with a ground at AFz. Horizontal eye movements were recorded with electrodes 
placed 1.5cm lateral to the outer canthus of each eye. Vertical eye movements were 
recorded with electrodes placed 3mm above the middle of the left eyebrow and 
1.5cm below the middle of the left bottom eyelid. Skin resistance was aimed at <5 
KOhms for all electrodes. A continuous acquisition system was employed and EEG 
data were electrooculogram (EOG)-corrected offline 53. The sampling rate of all 
channels was 500 Hz. A low pass filter with an attenuation of 40dB per decade above 
100 Hz was employed prior to digitization. 
The oddball paradigm consisted of a quasi-random sequence of 280 frequent 
background tones (500 Hz) and 60 infrequent target (1000 Hz) tones. Two targets 
could not appear consecutively. All stimuli (50 ms; 5 ms rise and fall time) were 
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presented binaurally at a volume of 75dB SPL with an inter-stimulus interval of 1000 
ms. Participants were instructed to press two buttons simultaneously (one for each 
index finger to counterbalance motor effects) when they heard a target tone and to 
ignore the background tones. Speed and accuracy of response were both equally 
stressed in the instructions. Before the actual test they were presented with a brief 
practice run to clarify the distinction between the two tones.
ERP scoring
Conventional ERP averages were generated at all electrode sites for target stimuli. 
Only stimuli with a correct response were included in the average. Before averaging 
each single trial ERP was filtered with a Tukey (tapered cosine) window. No signal 
was passed above 35 Hz. For the target stimuli waveforms, the peaks (amplitude and 
latency) of the N1, P2, N2 and P3 ERP components were identified, relative to a 300 
ms pre-stimulus baseline, at Fz and Pz (to capture possible compensatory effects). 
Using pre-determined latency windows, peaks were semi-automatically scored by 
BrainVision Analyzer 2: N1 (70-120 ms) and P3b (220-550 ms) and manually corrected 
by the first author (RvD). All scoring was checked by a second rater, and disagreements 
in scoring (<5%) were settled by the second author (MA). 
Current source density analysis
eLORETA software and statistical nonparametric mapping method (SnPM) 255-258 
were used (1) to replicate obtained results from the ERP peak-picking analysis by 
using a time-based analysis, and (2) to localize differences in brain activity between 
groups to cortical sources. This was done by analyzing time frames of averaged 
group ERPs with a t-test 259. Those timeframes that significantly differ in global field 
power were entered in a t-test on log-transformed current source density data in 
order to obtain the cortical sources responsible for the group difference in brain 
activity 260. eLORETA has been validated in multiple studies and the standard 10/20 
EEG system employing electrode montages with for example 25 electrodes has been 
proven sufficient for source localization 261. Statistics from both methods are corrected 
for multiple comparisons by means of a randomization procedure.
Statistics
Response was defined as a >50% decrease in HRSD17 score from baseline to week 
8. In this analysis, we primarily assessed responders vs. non-responders. Differences 
in age and sex were tested using a t-test or non-parametric tests (sex). In case of 
group differences in one of these measures, these variables were added as a 
covariate.
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For comparison of MDD vs. healthy controls as well as investigating treatment 
prediction a repeated measures ANOVA was conducted for P3 and N1 amplitude 
and latencies with within-subject factors Site (Fz or Pz), between-subject factors 
group (MDD vs. Controls or Response vs. Non-Response), treatment arm (For 
response analyses only: ESC, SER and VEN), Age (Young vs. Old) and sex. When 
significant interactions were found, univariate analyses were performed. The cut-off 
for young and old participants was set at 46 years based on age-related development 
of P3 amplitude as reported in our previous studies 79,262.
A partial correlation (correcting for age) was run between the percentage improvement 
on the HRSD17 between baseline and week 8, HRSD17 at intake and HRSD17 at week 
8 and the significant ERP components obtained.
All statistics for treatment prediction were performed on data from MDD participants 
who completed 8 weeks of treatment per protocol: participants who were dosed with 
their randomized medication for a minimum of 6 weeks and who returned for their 
week 8 visit and were still receiving their randomized medication at this visit (‘per 
protocol’ grouping). Significance level was set at p≤0.05 and effect sizes (ES) of main 
effects are reported in Cohen’s d.
Results
For the comparison between MDD and healthy controls, 1008 MDD patients were 
compared to 336 HC. For treatment prediction the ‘per protocol’ grouping consisted 
of 655 MDD participants. See table 5.1 for demographic information and remission 
and response rates for the whole MDD group and the separate treatment groups 
used for treatment prediction. The overall remission and response rates in this MDD 
sample were respectively 46% and 64%. Treatment was randomized as follows: 
Escitalopram (N=217), Sertraline (N=234) and Venlafaxine-XR (N=204). The 
treatment groups did not differ regarding age, sex, baseline MDD severity (HRSD17), 
anxiety severity (HRSD17), remission or response rates.
MDD Participants vs. Controls
There was no significant difference regarding age between MDD participants 
(M=37.84, SD=12.57) and HC (M=36.99, SD=13.08); t(1342)=-1.06, p=.29. Also, 
there were no significant differences regarding sex between the two groups 
(χ2(1,1344)=.004, p=.949).
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P3 amplitude
Repeated-measures ANOVA, yielded the following results for P3 amplitude: An effect 
of Site (F(1,1087)=695.37, p<.001), Sex (F(1,1087)=29.06, p<.001), a Group X Site 
interaction (F(1,1087)=6.19, p=.013) and a main effect of Group (F(1,1087)=14.61, 
p<.001). 
The significant Group x Site interaction was further analyzed. Separate univariate 
analyses for Fz and Pz demonstrated a main effect for Group (Fz: F(1,1091)=4.74, 
p=.03; Pz: F(1,1104)=18.14, p<.001). MDD participants had significantly lower P3 
amplitudes compared to HC at Fz (M=3.90 ± 5.48 vs. M=4.76 ± 6.41; d=0.14) and 
Pz (M=9.51 ± 5.93 vs. M=11.73 ± 7.31; d=0.33). 
A significant correlation between P3 amplitude at Pz and depression severity at 
baseline (HRSD17) was obtained within the group of MDD patients (r=-.069, df=803, 
p=.024). There were no significant correlations between P3 amplitude at Fz and 
baseline HRSD17 in MDD patients nor a correlation for P3 at Pz and Fz and baseline 
HRSD17 in healthy controls.
P3 latency
Repeated-measures ANOVA, yielded the following results for P3 latency: An effect of 
Site (F(1,1087)=98.420, p<.001), Sex (F(1,1087)=16.21, p<.001), Age 
(F(1,1087)=39.592, p<.001), a Group X Sex X Age interaction (F(1,1087)=5.487, 
p=.019) and no effect of Group (p=.167). 
Table 5.1   Demographic features of MDD patients and controls and treatment outcomes for patients who completed treatment per protocol.
Whole sample Per protocol completers Early drop-outs
MDD Controls Escitalopram Sertraline Venlafaxine-XR Escitalopram Sertraline Venlafaxine-XR
N 1008 336 217 234 204 N 119 102 132
Females 571 191 119 139 120 Females 59 52 82
Average Age (years) 37.84 (12.57) 36.99 (13.08) 38.85 (12.47) 38.34 (12.42) 38.46 (12.87) Average Age (years) 37.28 (12.93) 36.77 (11.85) 35.68 (12.65)
HRSD17 Baseline 21.88 (4.12) 1.15 (1.63) 21.75 (3.98) 21.95 (4.17) 21.50 (3.89) HRSD17 Baseline 21.77 (4.27) 21.89 (4.18) 22.66 (4.41)
HRSD17 Week 8 9.67 (6.43) 1.06 (1.43) 9.29 (6.60) 9.41 (6.08) 9.71 (6.22) HRSD17 Week 8 - - -
HRSD17 Anxiety
* 6.16 (1.99) 0.57 (0.97) 6.18 (1.95) 6.27 (1.96) 6.14 (1.85) HRSD17 Anxiety
* 6.04 (2.19) 5.86 (2.19) 6.08 (2.11)
% Remission (HRSD17) 48 47 44 % Remission (HRSD17) - - -
% Response (HRSD17) 60 67 63 % Response (HRSD17) - - -
Abbreviations: HRSD17, 17-item Hamilton rating scale for depression; MDD, Major depressive disorder; 
XR, Extended release. * measured at baseline
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The interaction effect of Group x Sex x Age was further investigated. Separate 
repeated measures analyses revealed that only young females with MDD had slower 
P3 latencies than young female healthy controls (F(1,433)=8.70, p=.003, dFz=-0.29, 
dPz=-0.28). There were no effects of Group in older females, or young and old males.
N1 amplitude
Repeated-measures ANOVA, yielded the following results for N1 amplitude: An effect 
of Site (F(1,1115)=551.479, p<.001), Sex (F(1,1115)=11.499, p<.001), Age 
(F(1,1115)=6.198, p=.013), a Group X Sex X Age X Site interaction (F(1,1115)=4.835, 
p=.028) and an effect of Group (F(1,1115)=11.423, p<.001). 
The Group x Sex x Age x Site interaction effect was further investigated by univariate 
analyses for both electrode sites per sub-group. The Group effect was found to be 
limited to young women on both electrode sites (Fz: F(1,444)=17.08, p<.001, d=-0.42; 
Pz: F(1,444)=14.16, p<.001, d=-0.40) and young men (only on Pz: F(1,335)=5.56, 
p=.019, d=-0.29), where MDD patients had smaller N1 amplitudes as compared 
to HC.
N1 latency
Repeated-measures ANOVA, yielded the following results for N1 latency: An effect of 
Site (F(1,1115)=5.993, p=.015), Age (F(1,1115)=7.883, p=.005) and no effect of Group 
(p=.300). 
Table 5.1   Demographic features of MDD patients and controls and treatment outcomes for patients who completed treatment per protocol.
Whole sample Per protocol completers Early drop-outs
MDD Controls Escitalopram Sertraline Venlafaxine-XR Escitalopram Sertraline Venlafaxine-XR
N 1008 336 217 234 204 N 119 102 132
Females 571 191 119 139 120 Females 59 52 82
Average Age (years) 37.84 (12.57) 36.99 (13.08) 38.85 (12.47) 38.34 (12.42) 38.46 (12.87) Average Age (years) 37.28 (12.93) 36.77 (11.85) 35.68 (12.65)
HRSD17 Baseline 21.88 (4.12) 1.15 (1.63) 21.75 (3.98) 21.95 (4.17) 21.50 (3.89) HRSD17 Baseline 21.77 (4.27) 21.89 (4.18) 22.66 (4.41)
HRSD17 Week 8 9.67 (6.43) 1.06 (1.43) 9.29 (6.60) 9.41 (6.08) 9.71 (6.22) HRSD17 Week 8 - - -
HRSD17 Anxiety
* 6.16 (1.99) 0.57 (0.97) 6.18 (1.95) 6.27 (1.96) 6.14 (1.85) HRSD17 Anxiety
* 6.04 (2.19) 5.86 (2.19) 6.08 (2.11)
% Remission (HRSD17) 48 47 44 % Remission (HRSD17) - - -
% Response (HRSD17) 60 67 63 % Response (HRSD17) - - -
Abbreviations: HRSD17, 17-item Hamilton rating scale for depression; MDD, Major depressive disorder; 
XR, Extended release. * measured at baseline
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Responders vs. Non-responders (HRSD17)
Responders did not differ from non-responders regarding sex, baseline MDD severity, 
baseline anxiety severity or type of treatment. However, responders were significantly 
younger than non-responders (M=37.42 ± 12.20 vs. M=40.51 ± 12.95; t(653)=3.05, 
p=.002). Since Age group was included as a between-subject factor, interactions 
with age group are included in the following analysis.
P3 amplitude and P3 latency
There were no effects nor interactions involving Response Type on the P3 amplitude 
(Group effect: p=.980) and P3 latency (Group effect: p=.296), suggesting no role of 
these measures in predicting antidepressant response.
N1 amplitude
Repeated-measures ANOVA, yielded the following results for N1 amplitude: An effect 
of Site (F(1,527)=272.271, p<.001), Sex (F(1,527)=4.747, p=.030), a Response Type 
X Sex interaction (F(1,527)=5.750, p=.017), a Response Type X Sex X Treatment arm 
interaction (F(2,527)=3.052, p=.048) and a trend effect for Response Type (p=.054). 
The Response Type x Sex X Treatment Arm interaction effect was further investigated 
by separate RM ANOVAs by sex. 
Figure 5.1   Averaged ERP measured at Fz of male responders and non-responders 
to venlafaxine-XR.
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In males, main effects of Response Type (F1,222)=8.94, p=.003, dFz=0.41, dPz=0.24), 
and Site were obtained. Furthermore, there were interaction effects of Response Type 
X Treatment Arm (F(2,222)=5.43, p=.005) and Response Type X Site (F1,222)=4.012, 
p=.046) in males. Separate RM analyses per treatment arm revealed no effects of 
Response Type with escitalopram or sertraline. However, with venlafaxine-XR there 
was an effect of Response Type with large effect sizes (F(1,68)=14.45, p<.001, 
dFz=0.89, dPz=0.73), Site (F(1,68)=49.01, p<.001) and an interaction effect of 
Response Type X Site (F(1,68)=5.04, p=.028). Separating this analysis into two 
univariate analyses for each site demonstrated a main effect of Response Type on 
both sites (Fz: F(1,71)=14.02, p<.001, d=0.89; Pz: F(1,71)=11.12, p=.01, d=0.73). 
Male responders to venlafaxine-XR have larger N1 amplitudes than non-responders, 
see figure 5.1 and 5.2.
In females, a main effect of Site (F(1,305)=143.38, p<.001) and an interaction effect 
of Site X Age X Treatment Arm X Response Type (F(2,305)=3.75, p=.025) were 
obtained. In all possible subgroups (young/old using escitalopram/sertraline/
venlafaxine-XR) there was no effect of Response Type on the frontal or parietal N1 
amplitude in females. 
Figure 5.2   Averaged ERP measured at Pz of male responders and non-responders 
to venlafaxine-XR.
90
CHAPTER 5
Within this group of males treated with venlafaxine-XR, N1 amplitude did not correlate 
with baseline HRSD17 for both Fz and Pz (p>.770), however N1 amplitude at Fz did 
correlate significantly with HRSD17 at week 8 (p=.043; r=.241; DF=69) and percentage 
improvement on HRSD17 (p=.030; r=.258; DF=69).
Splitting the Response Type X Treatment Arm interaction into separate RM ANOVAs 
per treatment arm ultimately led to the same conclusions.
N1 latency
Repeated-measures ANOVA, yielded the following results for N1 latency: An effect of 
Site (F(1,527)=14.981, p<.001) and a Response Type X Age group X Sex X Treatment 
arm interaction (F(2,527)=3.358, p=.036) and no effect for Response Type (p=.835). 
The Response Type X Age group X Sex X Treatment arm interaction effect was further 
investigated. Of all possible sub-groups (young/old males/females using 
escitalopram/sertraline/venlafaxine-XR) there was no significant effect of Response 
Type.
Post-hoc analysis of behavioral data
In a recent study on the same iSPOT-D study, cognitively impaired patients were 
found to have poorer treatment outcome 263. Therefore, post-hoc analyses including 
the cognitive impairment grouping factor (intact/impaired) from that study data were 
run. Inclusion of cognitive impairment as a factor did not alter the earlier results. In 
short, cognitive impairment did not refine earlier obtained results.
Post-hoc logistic regression analysis
In a subgroup of males that used venlafaxine-XR, a logistic regression analysis was 
performed with Response Type as dependent variable. Age (continuous), N1 
amplitude (Fz) and N1 amplitude (Pz) were simultaneously entered as predictors. 
Age (continuous) and N1 amplitude (Pz) did not contribute significantly to the model 
and were removed. The logistic regression model with one predictor, N1 amplitude 
(Fz) predicted 68% of Response Type. There were 58% of the non-responders and 
76% of the responders predicted correctly. The odds ratio for N1 amplitude (Fz) 
indicates that smaller values (i.e. higher negative amplitudes) increase the probability 
of being a responder, see table 5.2.
eLORETA analyses
The observed effects obtained with the peak-picking method were replicated using 
eLORETA analyses. In addition the eLORETA analyses provided cortical source 
localization of the observed P3 and N1 differences.
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MDD vs HC
The eLORETA software was applied to ERP data of MDD patients and healthy controls 
to find time points in the EEG where they significantly differed (t>3.878, p<.05). This 
was located at 344-384 ms post-stimulus which corresponds to the P3 interval. 
Between-group comparisons of the averaged current density distributions for this 
time segment were performed using a t-test on the log-transformed current density 
values. MDD patients’ P3s consist of less activity originating from the posterior 
cingulate and parahippocampal gyrus (BA31, t>3.498, p<.05, 2-tailed test), see 
figure 3. 
Temporal source analysis with eLORETA localized the difference regarding the N1 
between MDD patients and healthy controls at 104-120 ms post-stimulus. However, 
between-group comparison of averaged current density distributions within this 
timeframe yielded no significant differences in source space.
Table 5.2   Results of a logistic regression model with N1 amplitude at Fz as  
a predictor for Response Type.
95% confidence interval for odds ratio
B(SE) p Lower Odds Ratio Upper
Constant -1.493
N1 amplitude (Fz) -0.275 (0.087) .002 0.640 0.759 0.901
Note: R2=.14 (Hosmer & Lemeshow), .18 (Cox & Snell), .24 (Nagelkerke). Model χ 2(1)=13.95, p<.001.
Figure 5.3   MDD patients’ P3s consist of significantly less activity originating from 
the posterior cingulate (PC) and parahippocampal gyrus (PHG).
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Male responders to venlafaxine-XR vs. non-responders
Based on the peak-picking results, the same analysis was conducted for male 
responders vs. non-responders to venlafaxine-XR within the N1 interval (70-120 ms). 
The EEGs of male responders to venlafaxine-XR differed significantly from male 
non-responders to venlafaxine-XR at 88-104 ms post-stimulus (t>3.38, p<.05). 
Between-group comparisons of the averaged current density distributions of the time 
segment 88-104 ms were performed using a t-test on the log-transformed current 
density values. Male non-responders to venlafaxine-XR had significantly less activity 
originating from the left insula cortex, BA13 (t=-3.72, p=.048), see figure 5.4.
Discussion
In this study differences between MDD patients’ and healthy controls’ P3 and N1 
components of the auditory oddball ERP were investigated. Furthermore, these 
components were investigated for their value in predicting antidepressant treatment 
response. For validation purposes, two different analytic methods were used and 
both methods confirmed the main results. Additionally, CSD analyses were used to 
localize cortical sources of differences in brain activity between groups. 
MDD and P3
The P3 amplitude was smaller in MDD patients compared to healthy controls, with 
small effect sizes (dFz=0.14; dPz=0.33), and within the MDD sample P3 amplitude at 
Pz also correlated with MDD severity. A temporal global field power analysis confirmed 
this finding by significant global field power differences between the groups in a time 
Figure 5.4   Male non-responders to venlafaxine-XR have significantly less activity 
originating from the left insular cortex (BA13) at 88-104 ms post-stimulus 
(the N1 time frame).
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interval that corresponded to the P3. Using the largest sample size to date, this study 
confirms other findings of low P3 amplitudes in MDD patients 264-267. In addition, we 
were able to localize the difference in P3 amplitude between the groups to specific 
cortical structures, namely the posterior cingulate and the parahippocampal gyrus 
(PHG). The posterior cingulate is a large posterior hub in the default mode network 
(DMN) that has consistently been found to be abnormal in MDD 268. In this view, the 
PHG serves as a central hub within a sub-network that links the DMN to the 
hippocampus and thereby facilitates in memory 269. Cognitive problems associated 
with MDD (attention, working memory) might be related to inefficient information 
processing originating from suboptimal connections between the PHG sub-network 
and the DMN. The P3 amplitude might be a biomarker for indexing the neural 
interaction between the DMN and the PHG sub-network. This is highly speculative 
and requires further replication, but it would impose a new interesting view on the P3.
For the N1 it was found that MDD patients had low N1 amplitude, and this was 
specifically found for young subjects (age <46 yrs). This is in agreement with 270, 
albeit other studies have not found differences in N1 amplitude 232,266,271,272. The effect 
was validated by significant differences in global field power between the groups at 
a time point that corresponds to the time window of the N1, however, no significant 
differences in cortical current source densities between young MDD patients and 
young healthy controls at this N1 time window were found.
Treatment prediction
For antidepressant response prediction, we could not replicate earlier reports of 
differences in P3 amplitude between responders and non-responders to 
antidepressant treatment 231,232. Although, it has to be noted that these earlier reports 
used paradigms that were cognitively more challenging that the standard oddball 
paradigm from this study. Such paradigms might be more sensitive to predicting 
treatment response. Furthermore, the treatments that were investigated in these 
studies differed from our study. However, we did find male responders to 
venlafaxine-XR demonstrating larger (more negative) pre-treatment N1 amplitudes 
than non-responders, with large effect sizes (dFz=0.89, dPz=0.73) and N1 amplitudes 
at Fz correlated significantly with percentage improvement on HRSD17. Furthermore, 
this finding replicates our earlier study in 25 MDD patients using identical methods 
and the exact same oddball paradigm where this same effect was found for the 
whole group, including males and females 196. The source of this difference in N1 
amplitude was localized to the insular cortex. 
The insula has been associated with MDD and with antidepressant treatment response 
in other studies. In PET studies, hypometabolism of the anterior insula, among other 
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regions, was associated with response to fluoxetine 273, while increased metabolism 
of the insula was associated to remission after treatment with escitalopram 274. Using 
fMRI, increasing activation of the insula as venlafaxine treatment progressed was 
observed in MDD patients 275. In another fMRI study where unmedicated MDD 
patients performed a task requiring attention to bodily senses, insula activity was 
negatively correlated with depression severity 276. A role of the insula in MDD and 
treatment response seems evident, but it may come in different forms. For instance, 
four different functional regions of the insula were identified in a meta-analysis: 
activation in the anterior-ventral region was related to the social-emotional neural 
network; the mid-posterior region was activated in sensorimotor tasks; the central 
insula was activated in smell and taste; cognitive tasks activated the anterior-dorsal 
insula 277.
Since, the present study utilizes the oddball task, the insula region mapping to a 
cognitive brain network is plausible to be involved. Activation of the insula makes 
sense in a paradigm in which salience, attention and working memory are relevant. 
Indeed, the insula, together with the anterior cingulate, has been described as a hub 
in a salience network. Herein, it is involved in bottom-up detection of salient stimuli 
and facilitation of attention and working memory resources by switching between 
neural networks when a salient stimulus is perceived 278. 
Another explanation is that the effect that we found for the N1 amplitude is partly a 
reflection of the known relation between the LDAEP and treatment response (for 
instance 198,237.
Why the prediction holds for only male responders to venlafaxine-XR needs further 
testing. Sex-specific and treatment-specific effects have been observed in earlier 
iSPOT-D reports though. For instance, it was found that, in women only, pre-treatment 
alpha-asymmetry predicted treatment response for escitalopram and sertraline, but 
not for venlafaxine-XR 170. And in another study it was found that low frontal and low 
anterior cingulate cortex theta activity were associated with treatment response. 
Further post-hoc analysis revealed that the effect was mainly driven by one treatment, 
venlafaxine-XR 188. So, in sum, sex certainly seems to have an effect in predicting 
treatment response by EEG measures in, and furthermore, the effect may depend on 
the type of medication. The size of the iSPOT-D sample allows to observe these 
nuances.
The study had several strengths and weaknesses. The multi-center nature of the 
study along with the large sample size, are strong aspects of the study. Furthermore, 
the use of two different analysis (peak-picking and eLORETA) methods that resulted 
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in the same findings for P3 and N1 is a strength. A weakness is the already mentioned 
low spatial resolution of eLORETA (as implicated by the name: Low Resolution 
Tomography). It localizes brain activity exactly, but it does so on an approximate head 
model. Therefore, observed brain regions to which group differences in current 
source densities were located should be interpreted with caution. The analyses were 
also run for Remission, but this yielded no effects of N1 or P3 latencies/amplitudes 
(data not shown).
In conclusion, MDD patients compared to HC have low P3 amplitude with a small ES, 
unlikely to be of diagnostic utility. Furthermore, the N1 component from the ERP is a 
potential predictor for antidepressant treatment response to venlafaxine-XR, 
specifically in male MDD patients and with large effect sizes. Both main results also 
replicate results from previous small-scale studies, and the prediction results add 
emphasis on sex differences and localize differences to the insula. Regarding 
prediction of treatment outcome the observed results have limited clinical value. 
However, from an integrative perspective the N1 amplitude can provide more clinical 
value when it will be included in a sophisticated algorithm of multiple metrics such as 
EEG and neuropsychology 188,263. Future studies should investigate whether these 
markers, integrated with other markers, can improve prediction of treatment outcome. 
Furthermore, future treatment prediction studies in MDD should focus on sex as an 
important factor in analyses, and consider a priori stratification by sex.

A decomposition of the P3
In preparation:
van Dinteren, R., Hüster, R.J., Jongsma, M.L.A., Kessels R.P.C, & Arns, M. 
Differences in cortical sources of the event-related P3 potential between young and 
old participants indicate frontal compensation.
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Abstract
The event-related P3 potential as elicited in auditory signal detection tasks originates 
from neural activity of multiple cortical structures and presumably reflects an overlap 
of several cognitive processes. The fact that the P3 is affected by aging, makes it a 
potential metric for age-related cognitive change. The P3 in older participants is 
thought to encompass frontal compensatory activity in addition to task-related 
processes. The current study investigates this by decomposing the P3 using group 
independent component analysis (ICA). Independent components (IC) of young and 
old participants were compared in order to investigate the effects of aging. 
Furthermore, exact low-resolution tomography analysis (eLORETA) was used to 
compare current source densities between young and old participants for the P3-ICs 
to localize differences in cortical source activity for every IC. One of the P3-related 
IC’s reflected a different constellation of cortical generators in older participants 
compared to younger participants, suggesting that this P3-IC reflects shifts in neural 
activations and compensatory processes with aging. This P3-IC was localized to the 
orbitofrontal/temporal, and the medioparietal regions. For this IC, older participants 
showed more frontal activation and less parietal activation. The differences in cortical 
sources was localized in the precentral gyrus and the parahippocampal gyrus. This 
finding might reflect compensatory activity recruited from these cortical sources 
during a signal detection task.
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Introduction
The P3 (or P300) is a positive-going event-related potential recorded in the electroen-
cephalogram that peaks at approximately 300 milliseconds after stimulus presentation 
11. The P3 that is elicited in an auditory signal detection task, i.e. the oddball paradigm 
10, presumably reflects overlapping activity of several cognitive processes. It is 
generated by neural activity of multiple cortical structures 70.
The aging P3
The multifariousness of the P3 and the fact that it is affected by age-related changes 
in cognitive capacities, suggests it as a sensitive metric for cognitive performance 
21,79. In an earlier study the developmental trajectories of the P3 amplitude across the 
lifespan were compared between frontal and parietal electrode sites. It was 
demonstrated that the age-related changes were remarkably different between these 
locations. The parietal P3 amplitude increased in childhood to reach its peak in 
adolescence, then declined for the rest of the lifespan. In contrast, the frontal P3 
amplitude reached its peak at a much older age, 46 years, after which it remained 
constant for the rest of the lifespan. It was concluded that the P3 wave reflects 
different mixes of cortical activation depending on the location of measurement and 
the age of the participant, among other probable factors. The frontal P3 amplitude 
might reflect compensating activity from frontal regions that becomes more prominent 
as people age 262. 
This compensatory activity is possibly originating from the prefrontal cortex (PFC) 
that is related to higher order cognitive processes that are involved in regulating 
attention, working memory, and problem solving. These processes can be lateralized 
and it has been demonstrated that in older participants this lateralization reduces 
(this model is referred to as HAROLD, Hemispheric Asymmetry Reduction in Old 
Adults 279). This phenomenon might reflect changes in cognitive strategies used by 
older adults and/or neuroplastic reorganization in the aging brain 63. Similarly, the 
Compensation-related Utilization of Neural Circuits Hypothesis (CRUNCH) by 
Reuter-Lorenz and Cappell (2008) 5 posits that the aging brain, facing a decline in 
cognitive performance, can compensate to some degree by increasing activity in 
alternative connected neural networks 57,80. The P3 potential has a relatively long 
duration and consists of multiple overlapping slow potentials that reflect the several 
cognitive processes that are devoted to the task at hand. In line with this thought, 
there are many neural generators identified for the P3, e.g. the PFC, the temporo-pa-
rietal junction, primary auditory cortex, and other sources 70. The P3 might be 
exceptionally sensitive to pick up subtle changes in the relative contribution of the 
different cognitive processes that give rise to it. Therefore, it is a likely candidate for 
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capturing compensating activity that is increasingly allocated as people age. A simple 
comparison of P3 potentials between older and younger adults would be a first step. 
However, one has to extract and separate the various underlying sources of 
information that altogether give rise to the P3 potential in order to compare both age 
groups thoroughly.
Besides the often reported anterior shift in topography of the P3 in aging 66-69, Frodl 
et al. (2000) observed two subcomponents of the P3 by dipole source analysis with 
BESA that were differently affected by aging. The temporo-parietal P3 subcomponent 
was smaller in older adults whereas the frontal P3 subcomponent remained 
unchanged. These findings seem to explain the noted topographical change of the 
P3 with aging 280. Furthermore, there are reports of differences between younger and 
older adults in activation of the cortical regions that contribute to the P3 wave. For 
instance, it has been reported that P3s of older adults consist of more activation in 
prefrontal 69 and temporal regions compared to younger adults 69,281.
The decomposed P3
Because the spatio-temporal overlap of activity patterns from different neural sources 
inherent to scalp EEG recordings, methods for the decomposition have been brought 
forward to recover the activity patterns of sources that are otherwise mixed and 
hidden in multichannel EEG data. Independent component analysis (ICA) or principal 
component analysis (PCA), as applied to data of single as well as multiple subjects, 
have become prominent tools to recover neural source patterns from various 
measurement modalities (e.g., Eichele, et al., 2011; Huster et al., 2015). ICA achieves 
this by decomposing the original recordings such that the resulting sources (usually 
referred to as components) exhibit maximal statistical independence; PCA, on the 
other hand, results in merely uncorrelated component activity patterns PCA for EEG 
has a somewhat longer tradition, whereas studies applying ICA for the dissociations 
of P3 subcomponents is still somewhat scarce. Nonetheless, multiple studies have 
found independent components of the ERP using ICA that are physiologically 
plausible. Debener et al. (2005) decomposed concatenated single-trial ERP data 
from a novelty oddball paradigm and found two independent component clusters 
that respectively accounted for the novelty P3 and P3b responses 282. Brown et al. 
(2015) found a similar dissociation using PCA, and further reported a differential 
susceptibility of the two P3 subcomponents to drug exposure 283. Others also reported 
a dissociation of the frontal and parietal P3s from the succeeding slow wave activity 
that often appears as prolonged activity associated with the P3 peak (e.g.,284,285). 
Makeig et al. (1999) identified three IC’s in the ERP;  a frontoparietal component, a 
longer-latency parietal component, post-motor potential and a left frontocentral 
potential 286. 
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Aim
This study aims at unraveling aging effects on cognitive processes that are involved 
in signal detection tasks by identifying the independent sources that contribute to the 
P3 wave as observed in the recorded ERP. ICs derived from the complete sample of 
healthy participants will be reconstructed into single-subject EEG responses for each 
component. The acquired single-trial EEGs will be compared between younger and 
older individuals in the sample. Based on our earlier work 79, it is expected that one 
or more P3-ICs will emerge that differ between age groups, potentially reflecting 
compensatory brain activation (i.e. ICs with a more anterior topography). Further 
P3-ICs are expected that do not differ between age-groups (i.e. ICs with a more 
posterior topography) and rather reflect general task-related activation. Furthermore, 
exact low-resolution tomography analysis (eLORETA) 255 is used to compare current 
source densities between younger and older participants for the P3-ICs to localize 
differences in cortical activity for every IC. The differences in cortical activity are 
expected to mainly originate from anterior regions, reflecting compensatory activation. 
Older participants are expected to demonstrate more activation within relevant frontal 
regions. Also, differences to a lesser degree are expected in posterior regions.
Methods
Participants
The sample consisted of 99 healthy participants, aged 18 to 82 years all recruited 
and tested at the same location (Research Institute Brainclinics, Nijmegen, 
The Netherlands). All participants voluntarily gave written informed consent. Local 
IRB approval was obtained for all clinics. These data are a subset of the data reported 
in previous papers 79,262,287. Exclusion criteria were a personal or family history of 
psychiatric disorder, neurological disorder, brain injury, addiction or serious medical 
condition. Participants were required to refrain from caffeine, alcohol and nicotine for 
at least 2 hours prior to electroencephalographic data acquisition. The data collection 
was approved by the local IRB (CMO Region Arnhem Nijmegen; #2002/008).
Table 6.1. Demographics of the used sample.
N Mean age (SD) Males/Females
Young 50 23 (3.5) 19 / 30
Old 49 59 (9.6) 23 / 27
Total 99 41 (19.5) 42 / 57
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The sample was divided in a young and an old group with a cut-off at 46 years 262. 
Sample demographics are shown in table 6.1. The percentage of male/female 
participants did not significantly differ for the age-groups (Χ2(1,99)=0.529, p=.30). 
Additionally, post-hoc analysis of differences in global field power by sex by age-group 
revealed no significant differences in the ERPs at any frame.
Experimental paradigm
The oddball paradigm consisted of a quasi-random sequence of 280 frequent 
background tones (500 Hz) and 60 infrequent target tones (1000 Hz). Two targets 
could not appear consecutively. All stimuli (50 ms; 5 ms rise and fall time) were 
presented binaurally (via headphones) at a volume of 75dB SPL with an inter-stimulus 
interval of 1000 ms. Participants were instructed to press two buttons simultaneously 
(one for each index finger to counterbalance motor effects) when they heard a target 
tone and to ignore the background tones. Speed and accuracy of responses were 
both equally stressed in the instructions. Before the actual test participants were 
presented with a brief practice run to clarify the distinction between the two tones.
Electroencephalographic data acquisition
EEG acquisition was performed using a standardized methodology and platform 
(Brain Resource Ltd., Australia). Participants were seated in a sound and light- 
attenuated room, controlled at an ambient temperature of 22 °C. EEG data were 
acquired from 26 channels: Fp1, Fp2, F7, F3, Fz, F4, F8, FC3, FCz, FC4, T3, C3, Cz, 
C4, T4, CP3, CPz, CP4, T5, P3, Pz, P4, T6, O1, Oz and O2 (Compumedics Quick-Cap 
and NuAmps amplifier; 10-20 electrode international system) with a ground at AFz. 
Data were offline referenced to averaged mastoids. Horizontal eye movements were 
recorded with electrodes placed 1.5 cm lateral to the outer canthus of each eye 
(bipolar). Vertical eye movements were recorded with electrodes placed 3 mm above 
the middle of the left eyebrow and 1.5 cm below the middle of the left bottom eyelid. 
Skin resistance was <5 kOhms for all electrodes. A continuous acquisition system 
was employed and the sampling rate of all channels was 500 Hz. A high cut-off filter 
at 100 Hz was employed prior to digitization.
ERP scoring
Conventional ERP averages were computed relative to the target and background 
stimuli for all EEG channels per participant using Brain Vision Analyzer (Brainproducts, 
Germany). Only segments with a correct target response were included in the target 
average. Before averaging, the EEG epochs were filtered with a high-pass IIR filter of 
0.16 Hz (12dB/Oct) and a low-pass filter of 40 Hz (24 dB/Oct). Vertical and horizontal 
ocular correction was applied according to the Gratton algorithm 53. The segments 
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ranged from -200 to 800 ms around stimulus presentation. Segments were DC 
detrended and baseline corrected for the pre-stimulus interval of -200 to 0 ms. 
Segments were considered to contain artifacts when there was a difference of 20 μV 
or more between two subsequent data points, when the difference between the 
highest and lowest voltage within a 100 ms epoch exceeded 150 μV, when the 
maximum or minimum amplitude respectively exceeded 100 or -100 μV within -200 to 
300 ms, or when activity was measured below 0.5 μV in 50 ms. Rejected segments 
were not included in the calculation of the target average. Right before averaging 
baseline correction was done again.
Independent component extraction
To decompose the P3 into its constituent components, a group ICA on the 
multi-subject EEG data was set up 288,289. Hence, after preprocessing of the EEG an 
adjusted number of background and target trials was randomly selected from each 
subject’s available data. Note that the number of trials has to be the same for each 
subject in order to compute a group ICA. The number of background trials for further 
processing was restricted such that the average noise level of the condition-specific 
single-subject ERPs, computed as root mean squares of the baseline periods, did 
not differ between the background and target conditions. This procedure was 
implemented not to bias the group ICA towards background-related brain responses. 
These constraints led to a selection of 250 trials (200 background and 50 target trials) 
from each of the 99 participants that entered the analysis. 
Group ICA extracts statistically independent components consistently expressed 
across participants. In short, each single-subject dataset first undergoes an individual 
principal component analysis (PCA), thereby extracting most relevant and orthogonal 
time courses. These first-level principal components then are used as variables in a 
second, group-level PCA, now estimating most-relevant and orthogonal principal 
component time courses capturing activity patterns correlated across subjects. 
Ultimately, these undergo ICA that finally computes the statistically independent 
component time courses. Importantly, this nested procedure is capable of capturing 
some of the topographical variability we usually see with EEG events found in each of 
the single-subject datasets of a multi-subject study. Please refer to 288,289, for a more 
detailed description of the algorithm. 
A total of ten independent components were extracted using group ICA, because two 
procedures suggested this to correspond to the intrinsic dimensionality of the data. 
First, the inspection of the single-subject PCAs revealed that on average ten 
components explained about 95% of the variance of the scalp EEG data. Second, the 
ICASSO software package was used to assess the reliability and stability of the ICA 
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solutions of 100 runs 290. This combination of group ICA and ICASSO was used for 
evaluating models with 9, 10, and 11 components, and the ten-component solution 
revealed sufficient reliability and stability. Correspondingly, at each level of this 
analysis, including single-subject PCAs, group PCA, and group ICA, ten components 
were extracted. The ten resulting group components are characterized by their 
topographies and time courses, with estimations aiming at a maximal statistical 
independence of the latter, and naturally lead to a characterization of the latent data 
structure at the group level. 
To statistically analyze the differences between younger and older participants and 
to assess the brain sources underlying each independent component, the scalp EEG 
corresponding to each component was reconstructed for every single subject. 
Hence, for every subject the matrices estimated during the data reduction and group 
ICA steps were extracted and applied to the single-subject EEG. By means of these 
individual demixing matrices, the subject-specific component time courses and 
topographies were reconstructed that directly relate to the group-level components. 
Then, the subject-specific EEG for each component was reconstructed by multiplying 
each single component time course with its corresponding coefficients of the sub-
ject-specific mixing matrix. The subject-specific EEG patterns corresponding to 
certain independent components formed the basis for our statistical analyses. Group 
independent components as well as the subject-specific mixing and demixing 
matrices were computed using self-written MATLAB scripts that followed the 
procedures described in Eichele et al. (2011).
Independent component group analysis
The subject-specific EEG/ERPs were reconstructed for every independent component 
and then compared between younger and older subjects. The data was entered in 
the eLORETA software 256,257 that can analyze global field power of both groups at 
every time frame and produce a t-value for each time frame. Those time frames where 
the t-value exceeds the significance level (p<.01) comprise the ERP segments where 
the groups differ significantly from each other. These time frames were used in a 
spatial analysis.
The validated 291 eLORETA software yields images of current source density 
differences with exact localization, albeit that the spatial resolution is low. Current 
source density is calculated by squaring the weighed sum of scalp potentials for 
each voxel (A/m2). The computations are made in a realistic head model 292, using 
the MNI152 template 293 with standard electrode positions displayed on the scalp 
294,295. The three-dimensional solution space is restricted to cortical gray matter, as 
determined by the probabilistic Talairach atlas 296.
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The eLORETA software solves the inverse problem under the assumption that the 
smoothest of all possible solutions (meaning that neighboring voxels should 
demonstrate maximally similar activation) is the most plausible one. This comes at 
the cost of low resolution. Averaged current source density values for the two age 
groups were log-transformed and statistically compared. The software compares the 
groups on a voxel basis and identifies those voxels with t values that exceed a 
significance level. Additionally, the software corrects for multiple testing by means of 
a randomization procedure.
Results
ERP time frames
In figure 6.1 the grand average ERPs for younger and older participants at midline 
sites are shown. Figure 6.2 shows the head maps corresponding to the 200-520 ms 
post-stimulus time interval. The time frames where the difference in global field power 
between averaged group ERPs exceeded the significance level were at 54-74 ms and 
182-580 ms (t>4.953, p<.01).
Independent Components
ICs are ordered according to their contribution to the signal. The first four ICs revealed 
by ICA largely explained the signal. In figure 6.3 and 6.4, these ICs are displayed for 
the complete sample. Using eLORETA the current source densities were calculated 
for localization purposes. IC1 was localized to an orbitofrontal/temporal region and 
a medioparietal region; IC2 was localized to the precuneus/cingulate gyrus area; 
IC3 was localized to an area around the precuneus of the right parietal lobe, see 
figure 6.4.
IC group comparisons
The ICs were subjected to a time-domain analysis using t-tests to compare the two 
groups. For IC1, groups differed significantly from each other at 276-492 ms 
post-stimulus (t>4.282, p<.01). For IC2, the groups differed significantly from each 
other at 208-250 ms post-stimulus (t>4.266, p<.01). For IC3, the groups differed 
significantly from each other at 238-316 ms post-stimulus (t>4.190, p<.01).
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Figure 6.1   Grand average ERPs for younger and older participants at midline  
sites. Greyshading indicates significant group differences in global field 
power just after stimulus presentation and during the P3 interval 
(p<.01).
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The significant time frames were segmented into 20 ms epochs in order to reduce the 
number of tests that were run per analysis. For every IC separately, segments were 
analyzed for group differences in cortical source localization by voxel-by-voxel t-tests. 
For IC1, old participants had significantly more activation in the precentral gyrus and 
the parahippocampal gyrus (PHG). This was true for the early part of IC1, i.e. 276-296 
ms (t>3.364, p<.01), 298-316 ms (t>3.351, p<.01) and 318-338 ms (t>3.499, p<.01). 
In the 318-338 ms epoch there were differences in cortical activations, besides the 
precentral gyrus and PHG, localized to the insula, cingulate gyrus, uncus, subcallosal 
gyrus, inferior parietal lobule and post-central gyrus. Figure 6.5 shows the back-con-
structed ERPs of IC1  for both groups at Fz, Cz and Pz. It can be seen that IC1 has a 
higher frontal peak amplitude and a lower parietal peak amplitude in older participants. 
In figure 6.6 the differences between both groups in cortical activations for IC1 are 
demonstrated. For IC2, IC3 and IC4, there were no significant differences between 
younger and older participants regarding current source densities. 
Figure 6.2   Head maps corresponding to the P3 time interval of 200-520 ms 
post-stimulus of younger and older participants. Notice the reduced 
parietal activity over parietal electrodes, the higher activity over frontal 
electrodes, and the delayed onset in old participants compared  
to young participants.
Young Old
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Figure 6.3   The left half of the figure shows ERPs of IC1, IC2, IC3 and IC4 at Fz, Cz 
and Pz. The right half of the figure shows the topographies of these four 
independent components.
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Figure 6.4   Different views of cortical sources of the four independent components 
(IC) that were derived from the P3 potentials of the complete sample.
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Discussion
The aim of the present study was to unravel aging effects on oddball ERPs, and 
especially focusing on the P3 elicited in an auditory oddball paradigm. This was 
attempted by identifying the independent sources that contribute to the P3 and 
comparing these P3-ICs between younger and older participants. Furthermore, 
current source densities of the P3-ICs were compared between both groups to study 
differences in cortical activity. It was expected that some ICs reflect compensatory 
activation whereas others reflect general task-related processes.
The ERPs of younger and older participants differed significantly in global field power 
regarding all of the ERPs components, except the N1. There were three ICs identified 
as sources of the P3 wave (IC1, IC2 and IC3). For the whole group, IC1 was localized 
Figure 6.6   For IC1, older participants had significantly more activation than 
younger participants in the precentral gyrus and the parahippocampal 
gyrus. Difference in activation is depicted on a scale of p-values. Voxels 
with more activation in older participants have a red color scheme. 
Voxels with more activation in younger participants have a blue color 
scheme (there are none).
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to an orbitofrontal/temporal and a medioparietal region; IC2 was localized to the 
precuneus/cingulate gyrus region; and IC3 was localized to a region around the right 
precuneus, see figure 6.4. Our results are partly in line with the results reported by 
Makeig et al. (1999) who also found a fronto-parietal component and a second 
longer-latency parietal component among two other components 286. 
Individual ERPs were back-reconstructed based on the ICs. The three IC-ERPs of the 
two age groups differed significantly in the time domain. In the source domain, only 
IC1 showed significant differences in cortical source activity between older and 
younger participants. With IC1, older participants had more activation than younger 
participants in mainly the precentral gyrus and the parahippocampal gyrus. For the 
latter part of the P3 wave other cortical structures, i.e. the insula, cingulate gyrus, 
uncus, subcallosal gyrus, post-central gyrus and inferior parietal lobule, demonstrated 
significant differences in activation as well.
In sum, older participants use their available brain capacity differently from younger 
participants when they are performing the same oddball task. IC1 reflects a different 
mix of cortical sources in older participants compared to younger participants and 
therefore, this IC seems to be the most obvious P3-IC that partly might be reflecting 
compensatory processes in old age (i.e. the frontal P3 component we described 
earlier in Van Dinteren et al. (2014)). Differences in cortical activations were spread 
over multiple sources indicating there are possibly multiple neural networks involved. 
IC1 was localized to orbitofrontal and medial regions in the whole sample, which 
partly corresponds to the idea that compensatory activation comes from frontal 
regions.
Concluding, the P3 can be separated into three clear independent components. All 
of these components differ in activity between younger and older participants. 
Despite the significant differences found in the time-domain the effects were not 
present in the source localisation for all IC’s. The cortical sources of only one 
component differ between younger and older participants. In the back-reconstructed 
ERPs based on this IC it was seen that it had more frontal activation and lesser 
parietal activation in older participants compared to younger participants. This IC 
possibly reflects compensatory brain activation that is increasingly recruited as 
people age. In favour of CRUNCH, as people age the sources of IC1 are shifting 
whereby frontal contributions are increasing and parietal contributions are declining. 
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Summary
The aim of the present thesis was to examine the validity of an ERP index that is 
suitable for quantifying and indexing cognitive aging in both healthy and clinical 
populations. It has been hypothesized that older participants increasingly recruit 
brain activity originating from frontal regions of the cortex that compensate for 
age-related decline in other, task-related, cognitive resources 5,64,80. Therefore, a valid 
ERP index has to capture task-related cortical activity and compensatory cortical 
activity that is increasingly recruited with aging. A possible candidate lies within the 
P3 component. The ERP P3 is a wave of brain activation that is elicited in response to 
the presentation of an event, e.g., a stimulus during a specific task, and it is 
representative of cognitive processes related to the processing of such an event 14,17. 
Due to its clear link to several cognitive processes involved in information processing, 
the P3, was the main focus of this thesis.
The P3 is an interesting potential because it reflects the amount of cognitive resources 
that a participant allocates in a certain cognitive task 14. It is a large wave with a 
relatively long duration and therefore possibly reflects multiple cognitive processes. 
Because of the latter, it is especially suitable as an index for cognition in general. 
Additionally, it is a very robust and stable measure that has been investigated 
intensively during the past decades. Furthermore, the paradigms that are used to 
elicit the P3 are generally easy to understand and acquisition of the P3 can be done 
with relatively little discomfort for study participants. Both are important when the 
intention is to test participants in a wide age range, ranging from childhood to late 
adulthood.
In chapter 2, the literature on the P3 was reviewed and analyzed, specifically findings 
of the effect of age on the latency and amplitude of the P3. In this chapter a 
meta-analysis was performed on available data from the existing literature in order to 
obtain a concept of the age-related changes in the P3 across the entire lifespan. 
Developmental trajectories were created to observe the manner in which P3 latency 
and P3 amplitude change during the lifespan. Then, the models based on the 
literature were validated by data from a large cross-sectional dataset containing 
participants aged 6 to 87 years. In both datasets a logarithmic Gaussian model was 
the best fit for (inversed) P3 latency and amplitude development across the lifespan. 
In children the P3 latency shortens until a minimum is reached at the age of 22 years. 
After the minimum, the P3 latency gradually increases with aging for the rest of the 
lifespan. The P3 amplitude increases during childhood until a maximum is reached at 
16 years of age. For the remaining part of the lifespan the P3 amplitude decreases 
gradually. Concluding, the P3 follows a specific developmental trajectory across the 
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lifespan that is reflecting brain maturation and degeneration in respectively younger 
and older participants. Although the combined amplitude and latency describe the 
same P3 component, these two dependent variables demonstrate different 
developmental trajectories. This suggests that they reflect different aspects of 
age-related change. The P3 latency is possibly an index for brain efficiency and 
information processing speed whereas the P3 amplitude is understood to index 
allocated cognitive resources in a certain cognitive task.
Chapter 3 investigated whether the aging-related development of the P3 differed 
between frontal and posterior brain regions in the same cross-sectional dataset that 
was used in the preceding chapter. The preceding chapter already appreciated the 
role of compensatory brain activation that is increasingly recruited with aging. The 
best-fit models of age-related change in P3 latency and P3 amplitude were fitted 
again, but this time separately for the frontal and parietal cortex. When these models 
were compared, it was clear that P3 latency developed similarly across frontal and 
parietal positions. However, different best-fit models of age-related change in P3 
amplitudes for both sites were observed. The P3 amplitude measured at a frontal site 
developed slower, reaching its peak at a later age (46 years) and then remained 
approximately constant for the remainder of the lifespan. A lifespan trajectory of 
combined frontal and parietal P3 amplitudes was found to closely resemble the 
lifespan trajectory of behavioral performance. The results were interpreted within the 
concepts of the compensation-related utilization of neural circuits hypothesis 
(CRUNCH) by Reuter-Lorenz and Cappell (2008). This hypothesis states that to 
compensate for declining neural resources, older participants recruit additional 
neural resources of prefrontal origin and consequently preserve a stable behavioral 
performance. Indeed, it was observed that behavioral performance on the task in this 
study did not decline with age in adults. Following the results of chapters 2 and 3 the 
P3 across the scalp appears to be an excellent index for (compensated) cognitive 
resource allocation in healthy participants. It will be interesting how the P3 might be 
of value as an index for cognitive performance in clinical samples.
In chapter 4 the role of EEG and ERPs in predicting treatment outcome was reviewed. 
Based on prior ERP literature we hypothesized a potential role of the P3 in predicting 
treatment outcome. There have been observations of relations between P3 (latency 
and amplitude) and treatment prediction, but the results are ambiguous 297.  Although 
the main focus was on the P3, the N1 was also investigated. The N1 is interesting 
because of its relation to the loudness dependence auditory evoked potential 
(LDAEP), which is a derivative of the N1/P2 amplitude difference and how it changes 
with increasing stimulus intensity 236,237. The LDAEP and the N1 have been linked to 
antidepressant treatment response 196,198,237-239.
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Chapter 5 investigated the use of the P3 ERP component in treatment prediction 
further. This was done within the international Study to Predict Optimized Treatment 
in Depression (SPOT-D) project that provided 1008 MDD patients. The iSPOT-D study 
is a large multicenter randomized clinical trial including MDD patients that were 
randomized to one of three frequently prescribed antidepressants (Sertraline, 
scitalopram, Venlafaxine-XR). The P3 amplitude was found to be reduced in MDD 
patients compared to controls. Using source localization techniques this difference 
between the groups in neural activity could be localized to specific cortical regions, 
that is, the posterior cingulate and the parahippocampal gyrus. Unfortunately, the P3 
was not able to dissociate those who responded well to antidepressant treatment 
from those that did not respond. However, the N1 amplitude could indeed dissociate 
responders from non-responders to treatment although this effect was limited to a 
sub-group of males that were randomized to the SNRI Venlafaxine-XR. The N1 
amplitude might therefore be of value when included in a sophisticated algorithm of 
multiple additional metrics, such as EEG/ERP, genetics, neuropsychological 
measures and demographic variables.
That the P3 could not dissociate responders from non-responders to treatment was 
disappointing. The lack of predictive power might have been related to the fact that 
the P3 encompasses several cognitive processes and is therefore not specific 
enough. So, in chapter 6, the P3 signal was decomposed into separate independent 
components using independent component analysis to capture a more accurate and 
localizable reflection of frontal compensatory brain activation. The decomposed P3s 
were compared between young and old participants and localized to a cortical 
region. It was observed that one of the independent components reflected a different 
mix of cortical activity in old and young participants. This suggests that this specific 
independent component reflects shifts in neural activations related to increasing 
frontal compensatory activation in older participants. Using source localization, the 
cortical activity of this independent component was determined to be originating 
from the orbitofrontal/temporal region and the medial-parietal region of the cortex. 
The difference in cortical activation of this independent component between younger 
and older participants was localized to the precentral gyrus and the parahippocam-
pal gyrus.
Discussion and Conclusion
Although ideally one would use a longitudinal sample to investigate effects of aging, 
this would require decades of research time if one wants to cover the whole adult 
lifespan, which is not feasible for many research questions. The next best thing is a 
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cross-sectional dataset. The large collection of data that was gathered from the 
existing literature and the size of the cross-sectional dataset that was used for the 
empirical studies are two strong feats in this thesis. The fact that similar results are 
yielded from both samples is another strength. Additionally, there are some important 
benefits that come with the classic oddball paradigm that was used in the experiments. 
First, it is a paradigm that is easy to understand and can be utilized with people of all 
ages, from the very young to the oldest of the old. Second, it is a reliable and valid 
paradigm that has proven itself repeatedly over the past decades in many experiments.
However, the strengths described in the above paragraph at the same time introduce 
limitations to the study. All the participants performed in the standard oddball 
paradigm only. For more intensive research of compensatory brain activity, the 
standard oddball paradigm might not be challenging enough in every age group. A 
paradigm that allows for manipulation of the task load would be a valuable addition 
in future research. Another limitation is that the results that were observed are not 
applicable to individual subjects because the P3 varies highly inter-individually. In 
other words, the P3 can be a valuable index for compensated cognitive functioning, 
but one cannot make a reliable assessment of someone’s cognitive performance 
based on solely his or her P3 at a certain time. The aim of the chapter 6 was to 
acquire more insight in the independent components that contribute to the P3 and to 
define an independent component that reflects compensatory processes in older 
age. Although, there was such an independent component observed, it did not reflect 
purely the frontal compensatory processes, but the general parietal processes as 
well. In that sense, the analytical method was unsuccessful. 
In all, the results of the studies of this thesis clearly show that the P3 amplitude and 
latency change across age. Generally, P3 latency and amplitude optimize in childhood 
until adolescence. Then, a peak is reached and they decline for the rest of the 
lifespan. Remarkably, the peaks of the developmental trajectories of the P3 latency 
and P3 amplitude do not align. Both are measures that describe the same ERP 
component, but apparently do reflect different aspects of brain development or brain 
maturation. The P3 latency, expressing the temporal aspects of the P3, presumably 
reflects brain efficiency that is affected by neural speed of organization and utilization 
of cortical regions. The P3 amplitude, expressing the magnitude of the P3, presumably 
reflects neural capacity that is allocated in a certain cognitive task. However, it should 
be stressed that averaged P3 amplitudes are affected by variability in P3 latencies. 
For example, when single-trial ERP peaks show large variability in latencies, the P3 
amplitude of the averaged ERP will be decreased as a result.
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Although a decline in P3 amplitude in older participants was observed at a parietal 
region, no obvious decline in behavioral performance was noticeable. Possibly, this 
is due to older participants recruiting other cortical regions and thus being able to 
successfully compensate for the loss in neural capacity. In this view, compensatory 
activation is proposed to be originating from frontal cortical regions. Indeed, when 
the P3 amplitude trajectories across the lifespan measured at a frontal and a parietal 
site were compared, clear differences became apparent. Additionally, a trajectory of 
combined frontal and parietal P3 amplitudes aligned perfectly with behavioral 
performance. Furthermore, it was observed that the underlying sources that compose 
the P3 differed between younger and older participants. Older participants had 
increased contributions originating from the precentral gyrus and the parahippocam-
pal gyrus (PHG). The PHG is an interesting structure that was already found to be of 
importance in differentiating MDD patients from healthy participants. The PHG might 
serve as an important hub facilitating in information processing. The P3 might reflect 
changes in this structure’s function that lead to inefficient information processing in 
aging or clinical disorders.
To conclude, older participants use their available brain capacity differently from 
younger participants when performing the same behavioral task. By doing so, they 
are able to achieve a similar behavioral performance. There is a limitation to this 
compensatory process, however. As cognitive tasks get more complex, older 
participants might reach their capacity limits earlier than younger participants. This 
may not occur that often in many day-to-day tasks, making frontal compensation an 
effective and successful strategy in everyday life. Therefore, future studies should 
investigate the level of effectiveness of compensatory strategies by using increasingly 
complex experimental cognitive tasks. Also, inclusion of other imaging methods to 
measure recruited brain activity is valuable. For example, a (f)MRI can be combined 
with EEG or MEG to provide more spatial resolution and at the same time maintain a 
high temporal resolution. Other research directions may involve neuromodulation 
techniques such as transcranial direct current stimulation (tDCS) or transcranial 
magnetic stimulation (TMS) that can directly manipulate brain regions directly during 
the execution of a cognitive task in order to investigate the effects on task performance 
between younger and older participants. Finally, in a more qualitative approach, it 
would be interesting to investigate whether the age-related change in cortical 
activations is indicative of age-related change in cognitive strategies.
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Study N Percentage 
men
Mean age 
(years)
Age range 
(years)
Continent Target 
probability 
(%)
Eyes open / 
closed
Reponse  
type
Total number  
of stimuli
Stimulus duration 
(ms)
Stimulus loudness 
(dB SPL)
298* 55 49 49.8 15-89 Australia 15 - count 400 50 80
299* 12 - 56.6 28-81 North America 20 open press 300 50 72
300 32 88 20.6 18-24 Asia 20 - count - 90 75
301* 63 43 42.9 22-78 Asia 15 - press - - 75
302 21 - 34.0 22-55 Europe 20 - press - 40 64
303* 154 - 9.7 4-15 Asia 20 closed press 160 120 60
304 20 - 64.1 43-80 Europe 33 - count 200 20 -
305 20 50 39.3 25-59 Asia 25 closed press 160 100 75
306 16 69 31.9 - Europe 20 closed count 150 40 97
30 28 64 31.2 - Europe 15 - count - 40 75
307 29 100 11.5 - North America 10 closed count 264 50 64.5
308 78 40 28.6 - Asia 20 - press - - -
309 19 84 28.6 - Europe 20 closed press 500 40 80
310* 72 50 10.1 6-8 Europe 20 closed press - 50 60
311* 18 - 29.3 - Europe 20 closed count 150 40 97
312 36 61 27.5 - Europe 15 - count 130 50 -
313 41 100 24.5 20-33 North America 12.5 open press - 60 60
314 21 62 28.9 - Europe 20 - press - - -
315 23 65 30.6 - North America 20 open press - 50 60
316 15 73 43.7 28-70 North America 15 - press 600 40 -
317 29 62 66.7 46-79 Europe 20 open press - 100 -
318 19 37 26.8 - Europe 20 - press 200 100 65
319 40 73 36.7 20-54 Australia 15 open press 287 50 60
320 39 46 68.5 60-77 Asia 20 - press - 50 70
321 28 100 29.0 18-45 Europe 20 open press - 120 -
322 55 52 60.5 40-79 Asia 20 - count 400 50 -
323 15 100 27.0 - Asia 20 open press - 120 -
324* 32 56 31.0 10-68 Europe 20 closed count 100 120 60
325* 72 50 57.6 22-95 Europe 20 - count 240 80 -
326 18 67 15.5 - Asia 20 closed press 200 200 90
327 17 35 37.9 - Australia 15 open press 287 50 60
328 22 45 41.4 - Europe 15 - press - 100 -
329* 80 68 28.2 14-51 Australia 15 open press 287 50 60
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Study N Percentage 
men
Mean age 
(years)
Age range 
(years)
Continent Target 
probability 
(%)
Eyes open / 
closed
Reponse  
type
Total number  
of stimuli
Stimulus duration 
(ms)
Stimulus loudness 
(dB SPL)
298* 55 49 49.8 15-89 Australia 15 - count 400 50 80
299* 12 - 56.6 28-81 North America 20 open press 300 50 72
300 32 88 20.6 18-24 Asia 20 - count - 90 75
301* 63 43 42.9 22-78 Asia 15 - press - - 75
302 21 - 34.0 22-55 Europe 20 - press - 40 64
303* 154 - 9.7 4-15 Asia 20 closed press 160 120 60
304 20 - 64.1 43-80 Europe 33 - count 200 20 -
305 20 50 39.3 25-59 Asia 25 closed press 160 100 75
306 16 69 31.9 - Europe 20 closed count 150 40 97
30 28 64 31.2 - Europe 15 - count - 40 75
307 29 100 11.5 - North America 10 closed count 264 50 64.5
308 78 40 28.6 - Asia 20 - press - - -
309 19 84 28.6 - Europe 20 closed press 500 40 80
310* 72 50 10.1 6-8 Europe 20 closed press - 50 60
311* 18 - 29.3 - Europe 20 closed count 150 40 97
312 36 61 27.5 - Europe 15 - count 130 50 -
313 41 100 24.5 20-33 North America 12.5 open press - 60 60
314 21 62 28.9 - Europe 20 - press - - -
315 23 65 30.6 - North America 20 open press - 50 60
316 15 73 43.7 28-70 North America 15 - press 600 40 -
317 29 62 66.7 46-79 Europe 20 open press - 100 -
318 19 37 26.8 - Europe 20 - press 200 100 65
319 40 73 36.7 20-54 Australia 15 open press 287 50 60
320 39 46 68.5 60-77 Asia 20 - press - 50 70
321 28 100 29.0 18-45 Europe 20 open press - 120 -
322 55 52 60.5 40-79 Asia 20 - count 400 50 -
323 15 100 27.0 - Asia 20 open press - 120 -
324* 32 56 31.0 10-68 Europe 20 closed count 100 120 60
325* 72 50 57.6 22-95 Europe 20 - count 240 80 -
326 18 67 15.5 - Asia 20 closed press 200 200 90
327 17 35 37.9 - Australia 15 open press 287 50 60
328 22 45 41.4 - Europe 15 - press - 100 -
329* 80 68 28.2 14-51 Australia 15 open press 287 50 60
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Study N Percentage 
men
Mean age 
(years)
Age range 
(years)
Continent Target 
probability 
(%)
Eyes open / 
closed
Reponse  
type
Total number  
of stimuli
Stimulus duration 
(ms)
Stimulus loudness 
(dB SPL)
330* 59 47 56.1 22-92 Europe 20 - count - 80 80
331 33 45 27.8 - Asia 15 - press 270 50 75
332 25 64 28.9 - Asia 15 - count 400 200 -
333 36 58 25.8 20-37 Asia 20 - press - 100 70
31 18 56 26.0 22-34 Europe 20 - count 240 80 80
334 28 79 24.0 18-47 North America 15 - press 200 50 97
335 23 100 9.2 7-12 Europe 20 closed count - - -
336 16 56 11.9 10-13 Europe 20 open count - 100 -
337 20 50 25.0 19-31 Europe 20 - press 400 60 -
338* 16 50 26.5 20-34 Europe 20 - press - - -
339 21 52 7.0 - Europe 20 closed press 238 400 -
340 15 53 34.7 23-55 Europe 20 - count - 50 -
341 53 62 73.6 - Europe 20 closed press 100 100 80
342* 40 45 64.6 39-89 North America 15 - count - 50 80
343 16 81 67.6 - Europe 20 - count - 100 75
344 40 55 25.7 20-36 Asia 20 closed press - 100 70
345* 192 - 46.0 20-65 Europe 25 closed count 512 50 70
49 35 69 29.3 - Europe 14 - press - 50 -
346 15 100 21.3 16-25 Asia 20 closed press - 50 -
347 36 42 17.2 14-21 Europe 15 open press 300 50 -
348 42 48 40.2 18-60 Europe 20 - press 400 20 -
349 57 42 24.5 19-35 Europe 20 open press 400 - -
350 26 0 30.9 - Asia 20 closed press - 100 -
351* 68 50 50.0 20-80 Europe 20 - press 400 50 110
352 15 47 34.3 - North America 15 closed count 385 - 110
353 16 44 74.0 60-92 Europe 20 closed press 200 80 75
354 28 82 21.7 17-27 Europe 20 - press 300 100 75
355 40 60 25.7 18-39 Europe 10 closed press 384 500 -
356 20 60 69.5 Europe 15 - press 213 100 -
357 32 38 23.4 19-34 Europe 20 - count - 50 65
358 38 100 49.0 25-58 Asia 20 closed count 250 120 -
38* 57 47 13.0 7-18 Asia 20 closed count 100 50 -
77 17 53 23.9 - Asia 25 open press - 70 -
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Study N Percentage 
men
Mean age 
(years)
Age range 
(years)
Continent Target 
probability 
(%)
Eyes open / 
closed
Reponse  
type
Total number  
of stimuli
Stimulus duration 
(ms)
Stimulus loudness 
(dB SPL)
330* 59 47 56.1 22-92 Europe 20 - count - 80 80
331 33 45 27.8 - Asia 15 - press 270 50 75
332 25 64 28.9 - Asia 15 - count 400 200 -
333 36 58 25.8 20-37 Asia 20 - press - 100 70
31 18 56 26.0 22-34 Europe 20 - count 240 80 80
334 28 79 24.0 18-47 North America 15 - press 200 50 97
335 23 100 9.2 7-12 Europe 20 closed count - - -
336 16 56 11.9 10-13 Europe 20 open count - 100 -
337 20 50 25.0 19-31 Europe 20 - press 400 60 -
338* 16 50 26.5 20-34 Europe 20 - press - - -
339 21 52 7.0 - Europe 20 closed press 238 400 -
340 15 53 34.7 23-55 Europe 20 - count - 50 -
341 53 62 73.6 - Europe 20 closed press 100 100 80
342* 40 45 64.6 39-89 North America 15 - count - 50 80
343 16 81 67.6 - Europe 20 - count - 100 75
344 40 55 25.7 20-36 Asia 20 closed press - 100 70
345* 192 - 46.0 20-65 Europe 25 closed count 512 50 70
49 35 69 29.3 - Europe 14 - press - 50 -
346 15 100 21.3 16-25 Asia 20 closed press - 50 -
347 36 42 17.2 14-21 Europe 15 open press 300 50 -
348 42 48 40.2 18-60 Europe 20 - press 400 20 -
349 57 42 24.5 19-35 Europe 20 open press 400 - -
350 26 0 30.9 - Asia 20 closed press - 100 -
351* 68 50 50.0 20-80 Europe 20 - press 400 50 110
352 15 47 34.3 - North America 15 closed count 385 - 110
353 16 44 74.0 60-92 Europe 20 closed press 200 80 75
354 28 82 21.7 17-27 Europe 20 - press 300 100 75
355 40 60 25.7 18-39 Europe 10 closed press 384 500 -
356 20 60 69.5 Europe 15 - press 213 100 -
357 32 38 23.4 19-34 Europe 20 - count - 50 65
358 38 100 49.0 25-58 Asia 20 closed count 250 120 -
38* 57 47 13.0 7-18 Asia 20 closed count 100 50 -
77 17 53 23.9 - Asia 25 open press - 70 -
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Study N Percentage 
men
Mean age 
(years)
Age range 
(years)
Continent Target 
probability 
(%)
Eyes open / 
closed
Reponse  
type
Total number  
of stimuli
Stimulus duration 
(ms)
Stimulus loudness 
(dB SPL)
359 25 48 32.9 17-52 Asia 20 - press 250 50 80
360 110 33 11.3 10.2-12.9 North America 20 open press 400 50 -
361 17 71 57.2 27-81 Europe - open count 240 400 -
362 40 38 25.6 18-45 Asia 16.7 - count - 50 -
363 17 65 20.1 - Europe 20 open unknown / 
subjects choice
300 100 -
364 23 57 10.3 - Europe 20 closed count - - -
365 33 61 32.4 - Asia 15 - press 400 100 85
366 27 59 51.1 20-72 Europe 20 - press - 60 -
367 51 78 9.0 6-13 Asia 20 closed unknown / 
subjects choice
200 - -
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Study N Percentage 
men
Mean age 
(years)
Age range 
(years)
Continent Target 
probability 
(%)
Eyes open / 
closed
Reponse  
type
Total number  
of stimuli
Stimulus duration 
(ms)
Stimulus loudness 
(dB SPL)
359 25 48 32.9 17-52 Asia 20 - press 250 50 80
360 110 33 11.3 10.2-12.9 North America 20 open press 400 50 -
361 17 71 57.2 27-81 Europe - open count 240 400 -
362 40 38 25.6 18-45 Asia 16.7 - count - 50 -
363 17 65 20.1 - Europe 20 open unknown / 
subjects choice
300 100 -
364 23 57 10.3 - Europe 20 closed count - - -
365 33 61 32.4 - Asia 15 - press 400 100 85
366 27 59 51.1 20-72 Europe 20 - press - 60 -
367 51 78 9.0 6-13 Asia 20 closed unknown / 
subjects choice
200 - -

Appendix 2

133
APPENDIX 2
The model equations that were used are listed below. Descriptions of the models 
can be found on the Graphpad Prism website (www.graphpad.com/guides/prism/6/
curve-fitting).
Log Gaussian model 
Center is the x value of the peak of the distribution; Width expresses the width of the 
distribution in the same units as x. Height is the peak of the distribution expressed in 
y units.
Exponential growth model
The y value when x is zero defines y(0). The rate constant, k, is expressed in reciprocal 
of x values.
Exponential decay model 
The y value when x is zero defines y(0). The rate constant, k, is expressed in reciprocal 
of x values. Plateau is the y value when x is infinite.
Constrained linear model
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Van kind tot adolescent, van volwassene tot oudere; gedurende de gehele levensloop 
ondergaat het menselijk lichaam vele veranderingen. Dat geldt niet in de minste 
plaats voor het brein. In ons leven worden de mogelijkheden die ons brein ons biedt 
continu geoptimaliseerd. Zo heeft het brein van een jong kind bijvoorbeeld veel 
neuronen en synaptische verbindingen. (De synaps is de contactplaats waar informatie -
overdracht van de ene naar de andere zenuwcel plaatsvindt.) Op weg naar volwassenheid 
wordt een groot deel van de overtollige neuronen en synaptische verbindingen 
‘weggesnoeid’ (de Engelse benaming is synaptic pruning). De synaptische verbindingen 
die nauwelijks worden gebruikt zijn degene die worden weggesnoeid. De verbindingen 
die veel worden gebruikt worden daarentegen steeds sterker. Kortom, het brein leert. 
Met veroudering wordt er een nieuwe uitdaging aan het brein gesteld. Cognitieve 
vaardigheden zoals geheugen, informatieverwerking, aandacht en concentratie, 
gaan achteruit naarmate we ouder worden, een proces dat al rond het 30e levensjaar 
begint. De verminderde cognitieve vermogens bij oudere volwassenen gaan gepaard 
met fysieke veranderingen in het brein. Zo neemt bijvoorbeeld de hoeveelheid 
zenuw cellen in de frontale en temporale hersenkwabben af met veroudering. Toch 
merken de ouderen zelf in het dagelijks leven geen of slechts een geringe 
achteruitgang in hun cognitieve functioneren. Het gaat hier namelijk om een subtiele 
afname in cognitieve vermogens die alleen zichtbaar is tijdens experimentele taken. 
Op andere vaardigheden, zoals woordenschat, presteren ouderen juist beter dan 
jonge volwassenen. Woordenschat is namelijk een vaardigheid waarbij ervaring een 
belangrijkere rol speelt dan bijvoorbeeld informatieverwerkingssnelheid. Die levens-
ervaring speelt wellicht ook een rol in hoe het brein omgaat met de cognitieve 
uitdagingen die we veelvuldig aan moeten gaan. Het verouderende brein compenseert 
mogelijk voor fysieke tekortkomingen om zodoende een eindresultaat te behalen dat 
vergelijkbaar is met dat van een jonger brein. Reuter-Lorenz en Cappell publiceerden 
in 2008 een wetenschappelijk artikel waarin een model werd gepostuleerd met het 
acroniem CRUNCH. Deze vijf letters staan voor ‘compensation-related utilization of 
neural circuits hypothesis’ en dit model houdt in dat wanneer mensen een moeilijke 
taak moeten uitvoeren, zij compensatoire hersenactiviteit kunnen inzetten om 
zodoende alsnog een goede gedragsmatige prestatie te behalen. Deze additionele 
activiteit zou bij ouderen voornamelijk vanuit de prefrontale regionen van het brein 
afkomstig zijn. 
Het bestuderen van compensatoire netwerken in het brein - en hoe deze worden 
ingezet op individueel niveau door patiënten met (neuro)psychologische aandoeningen - 
kan mogelijk leiden tot nieuwe inzichten voor behandelingen en preventie van 
degeneratieve aandoeningen zoals dementie. Een dergelijke gepersonaliseerde 
behandelwijze lijkt de toekomst te hebben voor meerdere stoornissen. Het verkrijgen 
van inzicht in hoe neurale netwerken worden ingezet in patiënten kan belangrijke 
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informatie over de werking van het brein opleveren. Het is echter essentieel om eerst 
te begrijpen hoe neurale (compensatoire) netwerken een rol spelen in het brein van 
gezonde volwassenen. Om dit doel te behalen is het van belang dat niet alleen de 
prestaties op cognitieve taken worden onderzocht maar dat eveneens de processen 
die in het brein plaatsvinden gedurende die taak in kaart worden gebracht. Een 
methode om hersenactiviteit in kaart te brengen is het elektro-encefalogram, beter 
bekend onder het acroniem EEG, of hersenfilmpje. De eerste EEG-metingen bij 
mensen werden in het begin van de 20e eeuw door Hans Berger beschreven. Deze 
techniek maakt het mogelijk om hersenactiviteit te meten middels sensoren die op de 
buitenkant van het hoofd worden geplaatst en die de elektrische activiteit van het 
brein registreren.
Wanneer er tijdens een experimentele taak een stimulus wordt aangeboden, 
bijvoorbeeld een pieptoon of een object op een beeldscherm waarop de proefpersoon 
dient te reageren, vinden er verschillende processen plaats in het brein. De hersen-
activiteit die optreedt na het aanbieden van de stimulus is een representatie van de 
cognitieve processen die worden ingezet om de gevraagde taak uit te voeren. Het 
stukje taak-gerelateerde hersenactiviteit dat we zien in het EEG wordt een event-related 
potential of ERP genoemd. Kortgezegd is de ERP niets anders dan de taak-gerela-
teerde hersenactiviteit. De ERP kan gevisualiseerd worden als een golvende lijn 
bestaande uit een aantal pieken en dalen zoals te zien is in Figuur 1.1 in het eerste 
hoofdstuk. Wetenschappers hebben de pieken en dalen van het ERP genoemd naar 
hun polariteit, positief of negatief, en de volgorde waarin ze optreden. De derde 
positieve piek, de P3, is over het algemeen de grootste en meest opvallende piek in 
de ERP. Bij jonge, gezonde volwassenen treedt deze piek zo’n 300 milliseconden 
nadat een stimulus is aangeboden op. Daarom wordt de P3 ook vaak aangeduid als 
de P300. De P3 is al onderwerp van onderzoek sinds het begin van de jaren ’60.
Een klassieke taak om deze P3 op te wekken is het zogenaamde ‘oddball’ paradigma. 
In deze taak krijgen proefpersonen een reeks van tonen te horen die bijna allemaal 
dezelfde toonhoogte hebben, met af en toe een toon ertussen die een andere 
toonhoogte heeft. Aan proefpersonen wordt gevraagd om de afwijkende toon – de 
vreemde eend in de bijt, ofwel de ‘oddball’ - te ontdekken. Er wordt aan de 
proefpersonen gevraagd om zodra zij deze afwijkende toon horen te reageren, 
bijvoorbeeld door een knop in te drukken. De ERP na zo’n afwijkende toon bevat een 
duidelijke P3 golf. Die P3 golf ontbreekt in de ERP’s die gerelateerd zijn aan de 
reguliere tonen in de taak. Een schematische weergave van de ‘oddball’ taak is 
weergegeven in Figuur 1.2 in hoofdstuk 1.
Eén van de meest gangbare manieren om de P3 te kwantificeren is door het bepalen 
van de latentietijd (in milliseconde) en de amplitude (in microvolt) van deze golf in de 
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ERP. Hiervoor wordt eerst bepaald op welk punt de P3 maximaal is. Vervolgens wordt 
de latentietijd bepaald door te meten hoeveel milliseconden het duurt na het 
aanbieden van een stimulus, zoals een toon in het ‘oddball’ paradigma, tot de P3 het 
maximum heeft bereikt. De amplitude wordt bepaald door het verschil in microvolt 
tussen dit maximum en het potentiaalniveau voordat de stimulus wordt aangeboden 
te bepalen. In Figuur 1.1 in hoofdstuk 1 zijn de latentietijd en amplitude ter verduide-
lijking weergegeven. 
Nu kan de P3 worden beïnvloed door bepaalde aspecten van de experimentele taak 
te veranderen. Bijvoorbeeld, door de afwijkende tonen minder frequent aan te bieden 
vallen deze meer op. Dit leidt tot een hogere P3 amplitude. Het feit dat de P3 kan 
worden opgewekt door middel van onder andere de bovengenoemde experimentele 
taak is reden om aan te nemen dat de P3 bepaalde denkprocessen reflecteert. Een 
invloedrijke theorie van Emanuel Donchin beschrijft dat proefpersonen een mentale 
representatie creëren van hun omgeving. De omgeving is in het geval van de ‘oddball’ 
taak een serie van tonen van een gelijke toonhoogte. Wanneer een toon met een 
afwijkende toonhoogte wordt gepresenteerd, is die mentale representatie niet langer 
correct en dient te worden geüpdatet. Binnen deze theorie zou de P3 een reflectie zijn 
van dit update-proces. Hierdoor is de P3 een geschikte maat om subtiele veranderingen 
in het cognitief functioneren in kaart te kunnen brengen. Op deze wijze hebben wij het 
cognitief functioneren gedurende de gehele levensloop in kaart gebracht. Daarnaast 
heeft het ‘oddball’ paradigma als voordeel dat het een eenvoudige taak is die uit te 
voeren is door zowel jonge kinderen, volwassenen en ouderen.
In dit proefstuk hebben we allereerst een literatuuronderzoek uitgevoerd (hoofdstuk 2) 
waarin het effect van leeftijd op de P3 latentietijd en amplitude wordt onderzocht. 
Hiervoor zijn gegevens uit reeds eerder gepubliceerde onderzoeken verzameld en 
samengebracht om te analyseren. Het betreft hier uitsluitend gegevens van gezonde 
mensen van uiteenlopende leeftijden en bij wie middels een EEG een P3 is gemeten. 
Met behulp van deze data is een model opgesteld dat de verandering van de P3 
latentietijd en amplitude beschrijft gedurende de levensloop. Omdat er eveneens een 
eigen dataset beschikbaar was die gegevens bevat van ruim 1500 mensen van 6 tot 
87 jaar oud die een oddball paradigma hebben uitgevoerd, was het mogelijk het 
model op basis van de literatuur te toetsen tegen de resultaten van onze eigen 
dataset. Hieruit werd geconcludeerd dat naarmate kinderen ouder worden hun P3 
latentietijd afneemt en hun P3 amplitude toeneemt. Dit proces zet zich voort tot in de 
adolescentie waarna er een omslagpunt wordt bereikt. Na het omslagpunt is het 
proces omgekeerd voor de rest van de levensduur. De P3 volgt een ontwikkelings-
traject gedurende de levensloop dat de ontwikkeling van het brein bij jonge mensen, 
en de degeneratie van het brein bij oudere mensen, reflecteert. De omslagpunten 
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van de P3 latentietijd en amplitude liggen echter niet op dezelfde leeftijd. De P3 
latentietijd is het kortst zo rond de 22 jaar oud terwijl de P3 amplitude maximaal is zo 
rond de 16 jaar oud. In hoofdstuk 2 is dit in Figuur 2.3, 2.4 en 2.5 visueel weergegeven. 
Hoewel beide maten dezelfde P3 golf beschrijven, reflecteren ze verschillende 
aspecten van veranderingen in het brein die gerelateerd zijn aan veroudering. 
Mogelijk is de P3 latentietijd een indicatie van de efficiëntie van het brein, terwijl de P3 
amplitude een indicatie is van de mentale inspanning die wordt geleverd bij een 
bepaalde taak.
In het derde hoofdstuk werd onderzocht of de ontwikkeling van de P3 gedurende de 
levensloop verschilt, afhankelijk van de locatie waar de P3 wordt gemeten: namelijk 
boven het voorste, frontale gedeelte van het brein, of boven het meer naar achter 
gelegen pariëtale gebied. Toen deze metingen werden vergeleken viel op dat de 
ontwikkeling van de frontale P3 anders verliep dan die van de pariëtale P3. Zo 
bereikte de frontale P3 amplitude pas een maximum rond de 46 jaar oud. Bij de 
pariëtale P3 lag dit maximum rond de 16 jaar oud. Een ander verschil was dat de 
frontale P3 amplitude nadat het maximum was bereikt nauwelijks meer afnam voor 
de rest van de levensduur terwijl de pariëtale P3 amplitude dat wel deed. We hadden 
het vermoeden dat de frontale P3 een reflectie zou kunnen zijn van de compensatoire 
processen in het brein die worden beschreven door CRUNCH. We maakten daarom 
een derde model dat de ontwikkeling beschreef van de gemiddelde amplitude van 
de frontale en pariëtale P3. We dachten zo een weergave te hebben van de cognitieve 
processen die worden ingezet tijdens de oddball taak inclusief eventuele compensatoire 
processen vanuit het frontale deel van het brein. Het ontwikkelingsmodel van deze 
gecombineerde P3 amplitude bleek een goede weergave te zijn van de gedragsmatige 
prestaties op de oddball taak.
Het vierde hoofdstuk is een beschrijving van de literatuur over de rol van het EEG en 
de ERP’s in het voorspellen van het succes van behandelingen in patiënten. Hiermee 
is het een opmaat naar het vijfde hoofdstuk waarin we hebben gekeken of we met 
behulp van de P3 konden voorspellen welke patiënten met een depressie baat 
hebben bij een behandeling met antidepressieve medicatie. De P3 amplitude was 
lager bij depressieve patiënten dan bij gezonde mensen. Helaas bleek de P3 geen 
onderscheid te kunnen maken tussen patiënten die goed reageerden op medicatie 
en patiënten die geen baat hadden bij de medicatie.
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Dat de P3 geen geschikte voorspeller was voor therapiesucces bij depressieve 
patiënten heeft wellicht te maken met het feit dat de P3 een te algemene representatie 
is van meerdere opgetelde cognitieve processen in het brein. Men moet bedenken 
dat er veel hersenactiviteit plaatsvindt wanneer een cognitieve taak wordt uitgevoerd 
en dat de origine van deze hersenactiviteit een verscheidenheid aan hersenstructu-
ren kent. Met andere woorden, verschillende hersenstructuren zijn actief, maar deze 
gedifferentieerde informatie gaat verloren bij de EEG-meting. We meten dan enkel 
het gecombineerde signaal dat al deze structuren samen tot stand brengen. In het 
zesde hoofdstuk wilden we de verschillende hersenstructuren die betrokken zijn bij 
het genereren van de P3 beter in kaart brengen. Middels analyses die ontworpen zijn 
om het opgetelde EEG-signaal uit te splitsen naar de verschillende onderliggende 
signalen kwamen we tot vier signalen die ten grondslag liggen aan de P3. Met andere 
analyses konden we onderzoeken of de hersenstructuren vanwaar deze vier signalen 
ontstonden verschilden tussen jongeren en oudere mensen. Inderdaad bleek dat 
een van de vier signalen bij oudere mensen een andere bijdrage van hersenschors-
activiteit bevatte dan bij jonge mensen. Dit kan betekenen dat dit specifieke signaal, 
dat een onderdeel is van de P3, een verschuiving weergeeft in de hersenstructuren 
die worden ingezet om een cognitieve taak uit te voeren, wanneer mensen ouder 
worden. We hebben eveneens onderzocht waar het verschil in deze hersenschorsac-
tiviteit gelokaliseerd is in het brein. De analyses leidden ons naar de precentrale 
hersenwinding en de parahippocampale hersenwinding. Oudere mensen hadden 
meer hersenactiviteit vanuit deze structuren in het brein dan jonge mensen. De para-
hippocampale hersenwinding is een belangrijk schakelstation, of ‘telefooncentrale’, 
in het verwerken van informatie. De P3 reflecteert mogelijk veranderingen in de 
werking van dit schakelstation wat leidt tot een andere manier waarop informatie in 
het brein wordt verwerkt.
Kortom, oudere mensen zetten hun beschikbare cognitieve capaciteit op een andere 
manier in dan jonge mensen wanneer ze eenzelfde cognitieve taak moeten uitvoeren. 
Op deze manier behalen ze een gedragsmatige prestatie die vergelijkbaar is met die 
van jonge mensen. Het brein van oudere mensen compenseert op deze wijze voor 
de effecten van veroudering en behaalt zodoende toch het gewenste gedragsmatige 
eindresultaat. Er zijn echter wel grenzen aan deze compensatietechniek. Als 
cognitieve taken te complex worden, bereiken oudere mensen hun capaciteitslimiet 
sneller dan jonge mensen. In het dagelijks leven zal dit echter niet vaak voorkomen 
en is frontale compensatie een effectieve strategie.
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